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SYNTHETIC DEVELOPMENT OF THE TRI- AND PENTAMETHINE CYANINE 
CHROMOPHORE FOR BIOMOLECULAR INTERACTIONS 
 
by 
 
ERIC ANDREW OWENS 
 
Under the Direction of Dr. Maged M. Henary 
 
ABSTRACT 
The synthetic methodology of tri- and pentamethine carbocyanines and their 
interactions with biomolecules will be discussed in two chapters. The first chapter 
describes the preparation of halogenated carbocyanine dyes that display multiple 
charges; furthermore, these particular compounds were examined for their ability to bind 
G-quadruplex DNA with selectivity over duplex DNA and have potential for developing 
novel chemotherapeutic agents. The second section discusses the synthetic methods 
utilized to prepare trimethine cyanine fluorophores.  This chapter will show how varying 
the N-indolenyl substituients’ hydrophobicity from ethyl to phenylpropyl influences the 
binding to Human Serum Albumin (HSA); additionally, alternating the terminal 
heterocyclic moieties of the cyanine dye has a direct quantitative effect on the 
biomolecular interaction.  These identical compounds were recognized to be structurally 
analogous to agents that commonly interact with Protein Arginine Methyl Transferase 
(PRMT) and these compounds display low IC50 values toward inhibition of PRMT1 with 
unique NIR imaging properties. 
 
INDEX WORDS: Carbocyanine, Synthesis, Near-infrared, Chromophore, Dye, 
Halogenated, Tricationic, Fluorescence, G-quadruplex, Human serum albumin, 
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1 SYNTHESIS AND BIOPHYSICAL ANALYSES OF CHARGED AND 
HALOGENATED CARBOCYANINE DYES FOR G-QUADRUPLEX 
STABILIZATION 
The development of therapeutics for targeting cancer cells is a key goal among 
academic research labs and pharmaceutical companies. Common problems associated 
with current anti-cancer drugs include a lack of specificity, native cell toxicity, and in vivo 
ineffectiveness. Designing compounds that selectively target aberrant cellular processes 
requires distinguishing a pathway or protein within an abnormal cell, that is not present in 
normal, non-cancerous cells. This therapeutic mechanism may be best achieved via 
stabilization of the G-quadruplex structure. 
1.1 G-Quadruplex Introduction 
Eukaryotic chromosomal replication followed by precise segregation of genetic 
material forms the basis of the well-orchestrated cell division process.1-4 In particular, 
DNA fragments are lost during every cycle of replication, referred to as the end 
replication problem.3,4 As DNA polymerase replicates the 5'-G-rich end of the unzipped 
DNA strand, a RNA primer helps replicate the opposite strand of DNA. The leading 
chromatid is fully replicated, but the lagging chromatid with a guanine rich overhang on 
the 3' end loses DNA in each replication cycle.2-5 This end of the chromosome is known 
as the telomere (Figure 1.1). 
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Figure 1.1 – (left) Telomeric DNA in humans and the t-loop that caps the end of the 
telomere. (right) Diagram of the end-replication problem. 
 
Telomeres are comprised of various proteins and repeating DNA segments, that protect 
chromosomes from degradation.5,6  Essentially, telomeric fragments on the end of 
chromosomes help to maintain the genetic information needed for the cell to perform its 
designed function by providing a segment of noncoding DNA. After every cycle of 
somatic cell division, the telomeric length is shortened due to incomplete replication as a 
result of the end-replication problem.6 The shortening of telomeres has been linked to 
the process of aging; as telomere length approaches a critically short length, the cell 
undergoes replicative senescence and succumbs to apoptotic cell death.7 Although most 
cells die after the telomere reaches critical lengths, ~85% of cancer cells avoid terminal 
shortening of the telomere, thus maintaining the integrity of chromosomes. This results in 
an uncommon number of replication processes and abnormal cellular longevity.5,6 The 
enzyme responsible for lengthening the telomere is a reverse transcriptase enzyme, 
named telomerase.6  Telomerase utilizes a RNA primer to synthesize a new portion of 
telomere.  Five RNA nucleotides bind to the 3’ guanine tail, allowing the copying of 
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additional nucleotide segments based on the human telomere RNA template sequence.6 
Telomere sequences alone do not sufficiently protect the DNA of chromosomes that are 
vital to the function of the cell.1 Telomeres consist of a double helix segment ending in 
the guanine rich 3’ overhang strand.2 This guanine rich segment of nucleotides at the 
end of the telomere can form uniquely folded regions with interesting characteristics.1 
This overhanging strand can form stacked tetrads, referred to as G-quadruplex 
structures.5-20  As seen in Figure 1.2 (right), eight hydrogen bonds hold the tetraplex 
together around a central stabilizing metal cation, usually potassium.7,8,10 The 
quadruplex can be arranged in more complex orientations (Figure 1.2 left). The exact 
orientation of the quadruplex causes a variance in binding affinities of particular 
compounds for the tetraplex.11,12  
 
Figure 1.2 – (left) A schematic model for the hybrid conformation of the human telomere 
as determined by NMR. (right) General G-quadruplex structure with metal cation bound 
(commonly Na+ or K+) between the hydrogen bound nucleotides.10 
 
These self-assembled guanine tetraplexes have corresponding binding ligands in 
vivo; however, the structural function of these complexes remains unknown.  It is 
reported that these binding ligands help to stabilize the G-tetraplex structure, leading to 
the regulation of telomerase.16,17 Figure 1.3 shows how a G-quadruplex motif, stabilized 
by an external binding ligand, inhibits the telomere elongation by preventing telomerase 
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binding.  The active site of the enzyme is unable to recognize the binding site on the 
telomere due to its new formation in a stabilized stacked G-quadruplex structure.1 
Blocking the binding of telomerase to the human telomere through stabilization of the G-
quadruplex is a very potent strategy to deactivate the enzymatic elongation of telomeric 
sequences thus combating cancer cell’s ability to replicate limitlessly.18,19 Thus, G-
quadruplex stabilization using synthetic small molecule ligands is an attractive strategy 
for designing new anti-tumor drugs.16-27  Targeting telomerase has only been an active 
area of research for about the past 10 years leaving the field open for new innovations. 
Although current research attempting to synthesize intercalating agents and groove 
binding compounds for the stabilization of G-quadruplex complexes for telomerase 
inhibition has shown promising results, there are many rationally-driven approaches that 
are yet to be explored, particularly those that emphasize quadruplex over duplex DNA 
binding.18 
 
Figure 1.3 – Telomerase is active for telomeres with an available binding site, but 
telomeres ending in G-quadruplex motifs prevent telomerase binding consequently 
inhibiting the enzyme's ability to elongate or repair the telomere.5  
 
Stabilization of the G-quadruplex structure serves as a viable path to inhibit 
telomerase; however, alternate regions, known as oncogene promoter regions form G-
quadruplex strucutres.9,18  One commonly researched oncogene is known as c-myc.  As 
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with the enzyme telomerase, it exists in most native cells, but they are problematically 
overexpressed in cancer cells.  The difference in c-myc is that it is originally double 
stranded; whereas, the human telomere is single stranded.  This double stranded c-myc 
sequence will separate from the Watson and Crick base pairing in cancer cells which 
leads to their over transcription if these separate strands can be stabilized in the form of 
a G-quadruplex, then they will not be transcribed into proteins.  
1.2 Previous Work by Others 
The majority of binding agents that have been developed lack specificity and 
maintain high affinity for duplex DNA.  The molecular characteristics desired when 
designing quadruplex-binding agents remains unknown; however, a diverse library of 
compounds have been synthesized and tested for quadruplex interactions.  Published 
research suggests that the molecules being tested for G-quadruplex DNA stabilization 
and groove binding are typically rigid molecules that are very similar in structure (Figure 
1.4).10,16 However, these compounds cause serious side-effects from high affinity for 
duplex DNA.10, 16, 21 It is becoming increasingly recognizable that duplex DNA binding is 
a major limitation of G-quadruplex binding molecules strongly suggesting that specificity 
is extremely crucial for the design of telomerase inhibitors.1-21 
 
 6 
 
Figure 1.4 – (left) Diamino cryptolepine intercalating agents were tested to be non-
selective for G-quadruplex structures.16  (right) Platinum(II) Schiff Base Complex used 
ineffectively for G-quadruplex stabilization.10 
 
These compounds were found to bind G-quadruplex DNA but either in insufficient 
amounts or with limited specificity (i.e. they also bind duplex DNA).21 Similar to the 
previous compounds, the BRACO-19 compound, as seen in Figure 1.5, binds very well 
to G-quadruplex DNA structures and effectively stabilizes the complex. 
 
Figure 1.5 – An acradine-based binding agent named BRACO-19 that displays 
nonspecific duplex and G-quadruplex binding.21 
 
Other research groups have proposed that macrocyclic structures encompass the tetrad 
and stabilize the structure, while the large molecular structures cannot interact effectively 
with native duplex DNA, which provides the needed fidelity toward the quadruplex 
structure versus normal dsDNA.  Specifically, oxazole-based macrocyclic ligands interact 
strongly with the G-quaruplex structure with specificity due to the affinity for the top tetrad 
of the structure; this binding mode is theorized due the retention of a planar conformation 
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as proven by molecular modeling and X-ray crystallography.  The binding affinity of four 
compounds analogous to the macrocycle depicted in Figure 1.6 below were thoroughly 
evaluated using Fluorescent Resonance Energy Transfer (FRET), surface plasmon 
resonance (SPR) and circular dicroism (CD).28 
 
Figure 1.6 – The oxazole macrocyclic structure that was evaluated and proved 
successful in targeting the G-quadruplex structure.28 
 
Previous research indicates that compounds displaying aromatic characteristics with 
positive charge are successful G-quadruplex DNA binding agents. Based upon this fact, 
we rationalized that carbocyanine dyes might be successful binding compounds, specific 
to G-quadruplex structures due to the delocalized monocation inherent in these 
structures.29  
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1.3 Introduction to Carbocyanine Dyes 
Carbocyanine dyes are highly modifiable molecules with either symmetric or asymmetric 
heterocycles linked with a polymethine bridge, as depicted general structure in Figure 
1.7.29-52 These molecules are naturally occurring compounds that have extensive 
applications, including cancer imaging and nucleic acid detection.49 
 
Figure 1.7 – The general structure of carbocyanine dyes. 
Cyanine dyes have characteristics that make their cellular use extremely appealing.  
These compounds are generally non-toxic, stable towards chemical decomposition, 
display excellent biocompatibility, and are amenable to diverse chemical modifications. 
With multiple synthetically active sites, there exist a multitude of carbocyanine dyes that 
can be designed and tested.  Indocyanine green (ICG), a carbocyanine dye, has been 
proven to be potent as a cancer-imaging agent and was approved by the FDA nearly 50 
years ago.46 
Within the recent literature, an extensive number of cyanine dyes have been 
synthesized for various applications due to the diversity in function associated with this 
class of compound.  The following discussion serves as a brief review of the most recent 
high-impact publications concerning synthetic preparation of mono-, penta- and 
heptamethine cyanine.  A brief trimethine cyanine literature review will be presented in 
Chapter 2. 
n
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Vasilev et al. reported the synthesis of multiple tetra-cationic monomethine 
cyanine dyes analogous to thiazole orange with a 700-750 fold fluorescence intensity 
increase upon dsDNA intercalation making them more effective than previous 
compounds.50 These novel dyes were synthesized similar to previously reported 
methods, except they utilized a solvent-free quaternization of 4-chloroquinoline by 1,4-
dibromopropane in 30 seconds in excellent yield. These tetra-cationic monomethine 
cyanines (Figure 1.8) bind to DNA and RNA and allow scientists to more efficiently 
develop functional medications that target these structures. Increasing the cationic 
character of monomeric monomethine dyes directly induces a more highly fluorescent 
binding to dsDNA for more effective bio-analytical investigations of these structures.50 
Figure 1.8 – Synthetic preparation of a novel tetra-cationic monomethine cyanine dye for 
double stranded DNA binding. 
 
Alternatively, Ying et al. describe the efficient synthesis of multiple symmetric 
carbocyanine dyes containing functionalized mono-carboxylate moieties (Figure 1.9).52 
This library of dyes was prepared in greater than 60% yield with facile final purification. 
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Four negatively charged sulfonato groups provide excellent water solubility to these 
dyes, which serve as NIR imaging agents of microtubules within cells.  
 
Figure 1.9 – Synthesis of an NHS-Ester activated pentamethine cyanine dye for 
biomolecular conjugation.52 
 
This diverse classification of compounds has also found relevance in G-quadruplex 
interactions.53 The tri-, penta-, and heptacyanine dyes, shown in Figure 1.10, were 
synthesized using the benzothiazole (X = S) or the benzoxazole (X = O) heterocyclic 
subunits. 
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Figure 1.10 – The synthesized dyes used for quadruplx binding. 
The compounds were tested for guadruplex binding and the inhibition of the 
telomere elongating cancer-associated enzyme telomerase.  The trimethine thiazole, 
sulfur containing, dye with ethyl substituents showed 35% inhibition of telomerase in 
HeLa cell extracts utilizing 20uM dye concentration.53 
As shown in the recent literature, this class of compound has been modified to 
interact in various faucets of chemistry and chemical biology.49-53 This observation 
provides the rationale for utilizing this molecular class for developing novel compounds 
for medicinal purposes—specifically the interaction of DNA superstructures. 
1.4 Experimental Rationale and Goal 
As inhibition of telomerase has been widely recognized as a potent route toward 
the development of anti-cancer drugs, it is necessary to understand the pathways for 
preventing enzymatic activity.  The approach of stabilizing the G-quadruplex on the 
telomeric end of oncogene promoter sequences has been actively researched but a 
diverse set of cyanine dyes have yet to be fully examined as to their binding affinity and 
specificity toward the quadruplex structure.  Utilizing the inherent ability to greatly 
modify the core cyanine structure, many compounds can be examined to develop a 
N
X
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I
n
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methodology for determining the molecular characteristics needed to target the G-
quadruplex towards the design of novel chemotherapeutics. 
1.5 Synthesis 
The initial synthetic design focused on the preparation of Fischer indole-based 
hydrophobic analogs of the pentamethine cyanine structure.  It was hypothesized that 
the terminal heterocycles could undergo π-π stacking with the guanine subunits of the 
quadruplex structure; furthermore, using a phenylpropyl substituent may increase this 
binding affinity in a similar fashion.  Using commercially obtained 2,3,3-
trimethylindolenine (1) and either butyl or phenylpropyl halide, quaternized ammonium 
salts were afforded in acetonitrile using a bimolecular nucleophillic substitution (SN2) 
reaction as shown in Scheme 1.  The second step proceeded by base-catalyzed 
condensation of salts with malonaldehyde bisphenylimine hydrochloride (7) in acetic 
anhydride and sodium acetate, which provided the final compounds 8-11, as shown 
below in Figure 1.11. 
 
 
Figure 1.11 – Synthetic preparation of hydrophobic pentamethine cyanines for G-
quadruplex binding. 
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After the analysis of these compounds was performed, the UV-Thermal Melting 
data—used as a screening methodology for DNA binding—showed negligible binding to 
the G-quadruplex target.  Knowing that DNA intercalation and groove binding agents 
display high degrees of aromatic character, similar pentamethine cyanines were 
prepared with an increased π system using the benz[e]indole heterocycle.  This 
incorporation not only increases the potential for hydrophobic stacking interactions but 
the extended conjugation within the chromophores increases the absorption and 
emission wavelengths.  The final compounds 10 and 11 and were prepared using 
identical reaction methods as discussed in Figure 1.11, starting with 2,3,3-
trimethylbenz[e]indole (2).  Recognizing the negatively charged characteristic of the 
quadruplex structure, addition of multiple cations to the cyanine structure seemed to be a 
logical course to pursue.  Reacting the previously discussed compounds 1-2 with 3-
bromopropyl trimethylammonium bromide (BrTMAB) under anhydrous conditions 
provided the corresponding dicationic salts 18 and 19 that were used to make the 
pentamethine cyanine dyes 23 and 24, as shown in Figure 1.12.  An increase in DNA 
melting temperature—suggesting an increase in quadruplex binding—was observed with 
dye 23, which displays increased cationic character and the most simple indole structure.  
This possibly suggests increased steric hindrance arising from the larger 
benz[e]indolenine prevents interaction with DNA.  We further pursued changing the 
structure of the heterocyclic moieties to observe the change in DNA interactions. 
In order to incorporate additional modification into the carbocyanine core 
structure, functional groups were added using 4-substituted phenylhydrazines, including 
the electron donating methoxy group and the electron withdrawing chlorine and bromine 
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moieties.  The phenyl hydrazine hydrochlorides 12-14 were underwent a Fischer-indole 
type cyclization reaction with 3-methyl-2-butanone to yield the corresponding 
heterocycles 15-17.  These were then used to prepare the di-cationic salts and using 7 
the final dyes 25-27 were synthesized in anhydrous conditions.  
 
Figure 1.12 – Synthetic preparation of tricationic pentamethine cyanines for G-
quadruplex binding. 
 
The analogs 25-27 display differences in electron density around the terminal 
heterocycles, and they were subjected to UV-Vis thermal melting to screen for G-
quadruplex binding efficacy.  The halogenated compounds 26 and 27 showed very 
strong and specific quadruplex binding where the methoxy derivative showed weak 
binding association but maintained the specificity for the tetraplex. Correspondingly, 
additional analogs were designed to incorporate additional halogen moieties within the 
polymethine chain of the chromophore.  The meso carbon can be modified by 
synthesizing the Vilsmeier reagents 30 and 31 by reacting aniline with either mucochloric 
28 or mucobromic 29 acid in ethanol with light heating.  These reagent 7 analogs were 
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employed in subsequent reactions with di-cationic di-ammonium salts 18-22 to prepare 
the meso-halogenated pentamethine cyanines 32-41, shown in Figure 1.13. 
 
 
Figure 1.13 – Synthetic preparation of various meso-substituted tricationic pentamethine 
cyanines for G-quadruplex binding. 
 
The synthetic experimental methods and corresponding spectral data for the reported 
compounds appear in the accompanying appendix; however, explanation of a single set 
of data should be in addition to the spectrum alone.  Taking 26 the di-chlorinated 
pentamethine dye with tricationic character was thoroughly analyzed using 1HNMR, 
13CNMR, and LC/ELSD/MS.  The proton NMR spectrum shows an initial singlet arising 
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from the two Fischer-indole dimethyl groups at 1.780 ppm followed by an unresolved 
pentet that arises from the central hydrogens of the propyl group attaching each of the 
quaternized nitrogen centers.  At approximately 3.250 ppm, a large singlet resonates due 
to the presence of 18 hydrogen molecules accompanying the trimethylammonium 
bromide substituents.  Further downfield, a complicated triplet is present corresponding 
to the nearest hydrogens to this nitrogen center. The carbon-based protons closest to 
the aromatic nitrogen center will be more de-shielded and should be shifted downfield 
appearing at 4.245 ppm.  Further downfield are the hydrogen atoms on the polymethine-
bridge and those directly attached to the aromatic systems.  The doublet at 6.601 ppm, 
the triplet at 8.357 ppm and the triplet at 7.119 ppm are all associated with the 
pentamethine-hydrogens leading from the terminal nitrogen to the meso-carbon, 
respectively.  The complicated signal between 7.439 and 7.507 ppm are the neighboring 
hydrogens on the aromatic system at the 6 and 7 positions of the substituted Fischer-
indole ring.  The nearby chlorine atom distorts the electronic distribution, which 
contributes to the lack of signal clarity.   
Compound 26 was then further characterized by 13CNMR, which provides 
information about the carbon atoms in the analyzed molecule.  The resonating frequency 
is 100 MHz and the experimental set-up decouples the hydrogen molecules from the 
system while analyzing the 13C isotope present. The chemical shift values from the 
carbon NMR spectra are δ 20.89, 26.50, 40.58, 49.35, 52.57, 63.05, 104.20, 111.92, 
122.72, 127.75, 128.49, 130.54, 140.59, 143.15, 155.05, 173.28 ppm. Each peak 
represents a non-equivalent carbon molecule and there are 16 non-equivalent carbons 
with 16 peaks present in the well-resolved NMR spectrum (Appendix 1). 
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To complete the analysis and characterization required to ensure the presence of 
an analytically pure compound, LC/ELDS/MS was performed using a reversed phase C18 
column, water/acetonitrile, a SEDEX 75 ELSD and a Waters Micromass TOF MS.  The 
absorbance spectrum obtained showed the presence of a single component, the ELSD 
showed a solvent peak and further showed a sharp peak indicating the high purity of the 
injected compound.  The mass spectrum associated with both the absorbance and ELSD 
detectors provided two peaks that represented the synthesized compound.  The mass 
spectrometer detects the presence of mass/charge (m/z) ratios.  This is usually the result 
of a +1 or -1 charge; however, the molecular structure is initially tri-cationic leading to the 
possibility of having multiple ion peaks.  The mass of the full compound (without the 
three corresponding bromine counterions) is 623.3631 g/mol.  This mass, paired with the 
three charges, yields an m/z value of 207.7867, which can be seen in the mass spectrum 
as 207.755.  Additionally, a single hydrogen fragment would yield a negative charge on 
the molecule, giving a net +2 charge.  This would give another m/z peak at (M-1)/+2 
311.1815 and the spectrum shows 311.1284.  The presence of both molecular peaks 
shows the presence of the proposed compound. 
The screening method used to identify potential lead compounds suggested 
similar, albeit higher, binding affinities of tri-halogenated compounds toward 
quadruplexes when compared to their mono- and di-halogenated counterparts 
suggesting they participate in similar binding modes to the quadruplex.  A more 
thoroughly detailed examination of the compounds’ binding properties is discussed in 
Section 1.6, below. 
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1.6 Biophysical Evaluation 
The synthesized cyanine derivatives were thoroughly analyzed using various 
biophysical techniques to examine the binding mode to G-quadruplex DNA.  The initial 
method used to study the interactions was UV-Vis thermal melting for the general 
screening of prepared compounds.  The UV-Vis thermal melting experiment involves 
the single wavelength absorption analysis with an increase in temperature to observe 
the loss of DNA tertiary integrity; the quadruplex structure is analyzed at 295 nm, while 
260 nm is used to observe duplex DNA melting.  This is directly influenced by the 
presence of an external binding ligand, where the original DNA melting temperature is 
the standard and a stabilizing ligand should increase the temperature of melting; this is 
referred to as the ΔTm value or the change in the temperature of melting.  Consequently, 
qualitative binding properties can be determined using this technique and ΔTm values 
were experimentally obtained for the synthesized pentamethine dyes using various DNA 
segments corresponding to the human telomere, c-myc oncogene promoter region and 
duplex DNA.  The duplex DNA was included in the study to examine the specificity 
toward G-quadruplex binding which, as aforementioned, has been a major problem in 
quadruplex binding agents due to native cell cytotoxicity. 
(Integrated DNA Technologies, San Diego, CA). 
HTelo G4 (22 mers): 5’-AGG GTT AGG GTT AGG GTT AGG G-3’ 
c-myc (19 mers): 5’-AGG GTG GGG AGG GTG GGG A-3’ 
Duplex: 5’-CGG AAT TCG CTT TTG CGA ATT CGC-3’ 
The ΔTm values corresponding to binding affinity of the prepared hydrophobic dyes in 
Figure 1.11 are shown in Table 1.1.  
 19 
Table 1.1 – The change in melting temperature for human telomere titrated with various 
ratios of different compounds.  The values for compounds 8 and 10 were not recorded. 
Indole Heterocycle Compound ID 1:1 ΔTm (oC) 2:1 ΔTm (oC) 4:1 ΔTm (oC) 
N-ethyl 8 N/A N/A N/A 
N-phenylpropyl 9 1.0 1.6 -3.9 
Benz[e]indole 
Heterocycle Compound ID 1:1 ΔTm (
oC) 2:1 ΔTm (oC) 4:1 ΔTm (oC) 
N-ethyl 10 N/A N/A N/A 
N-phenylpropyl 11 0.0 -0.4 -4.3 
 
As mentioned in the synthetic portion above, the hydrophobic compounds’ failure to 
interact with quadruplex DNA directed the synthesis of compound 23 which has three 
cations that was hypothesized to interact with the highly negatively charged DNA 
structure.  The compounds depicted in Figure 1.12 and Figure 1.13 were also analyzed 
to determine their stabilization to two different DNA strands, the duplex DNA and human 
telomere and is shown in Table 1.2.  
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Table 1.2 – The 4:1 ratio was determined to me the most accurate for determination of 
melting temperature for human telomere titrated with various compounds.   
-Tricationic - 
Non-halogenated Compound ID 
4:1 ΔTm (oC) 
Human Telomere 
4:1 ΔTm (oC) 
Duplex DNA 
H, H, H 23 X X 
Mono-halogenated Compound ID 4:1 ΔTm (
oC) 
Human Telomere 
4:1 ΔTm (oC) 
Duplex DNA 
H, Cl, H 32 12.2 0.9 
H, Br, H 37 11.6 0.9 
Di-halogenated Compound ID 4:1 ΔTm (
oC) 
Human Telomere 
4:1 ΔTm (oC) 
Duplex DNA 
Cl, H, Cl   26 X X 
Br, H, Br 27 15.6 X 
Tri-halogenated Compound ID 4:1 ΔTm (
oC) 
Human Telomere 
4:1 ΔTm (oC) 
Duplex DNA 
Cl, Cl, Cl   35 12.0 -0.8 
Br, Cl, Br  36 10.2 X 
Cl, Br, Cl   40 14.8 X 
Br, Br, Br 41 17.7 1.2 
Literature Comparison Compound ID  4:1 ΔTm (
oC) 
Human Telomere 
4:1 ΔTm (oC) 
Duplex DNA 
Acridine-Based BRACO-19 25.9 11.2 
 
The ΔTm data reveal interesting characteristics about the halogenation of the cyanine 
dye structure.  The tri-halogenated compound 41 containing three bromine moieties 
shows the highest binding to the quadruplex structure while maintaining specificity to 
duplex DNA. This quadruplex stabilization was only slightly lessened when comparing 
the trihalogenated 41 and the di-brominated compound 27  
The screened compounds were further evaluated by surface plasmon resonance 
(SPR) to quantitatively determine a binding constant to both human telomere and the c-
myc oncogene promoter region.  The tricationic dyes were the strongest binding agents 
to G-quadruplex DNA and maintained the high fidelity discovered by the other tricationic 
analogs; however, the evaluation by these compounds by SPR proved difficult due to the 
trend to highly aggregate and become sticky.  The mono-brominated provided the most 
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accurate and precise results via SPR and are reported in lieu of the tri-brominated 
compound despite the lower binding to the quadruplex structure. The SPR graph is 
depicted below in Figure 1.14, which reveals the specificity of these compounds for the 
c-myc G-quadruplex structure over the human telomere sequence. 
 
 
Figure 1.14 – The steady state SPR and correlating best-fit curves for mono-brominated 
pentamethine cyanine dye 37.  A 400 s dissociation time, a flow rate of 25 µL/min, and a 
temperature of 25 ˚C were used.  Biotin labeled DNAs on chip – hTelo 22, c-myc19, and 
AATT hairpin. 
 
After determining the higher affinity for c-myc DNA by SPR, the mass spectroscopy of 
bound structures to c-myc was performed to determine the ratio of dye to DNA during 
interaction.  This experiment revealed that at a 1:1 ratio of dye:DNA a 1:1 binding ratio is 
observed; however, when the amount of dye is increased to a 4:1 ratio, another binding 
molecular peak arises that correlated to the dually bound c-myc structure with two of the 
mono-halogenated dyes binding the quadruplex as seen at m/z = 1842.7 in Figure 1.15. 
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Figure 1.15 – Three mass spectra of different solutions in 10% methanol containing 
meso-brominated pentamethine cyanine dye 37 in different ratios (0:1, 1:1 and 4:1) with 
10µM c-myc DNA. 
 
1.7 Conclusions 
The design and synthesis of pentamethine cyanine dyes yielded strongly binding 
agents that are G-quadruplex specific.  These compounds should be useful in gaining 
crucial knowledge about the molecular characteristics required to target this structure.  
An interesting step to proceed would be to perform x-ray crystallography on the bound 
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complex to more accurately determine the mode of interaction between the DNA 
superstructure and the halogenated pentamethine cyanine chromophores.	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 24 
2 MODIFICATION OF THE TRIMETHINE CYANINE STRUCTURE USING VARIOUS 
HYDROPHOBIC SUBSTITUIENTS FOR BIOMOLECULAR INTERACTIONS  
2.1 Introduction to Trimethine Carbocyanines 
As aforementioned in Chapter 1, cyanine dyes contain a polymethine bridge that 
can be shortened or lengthened using established synthetic methodology to alter the 
absorption and emission characteristics of the final compounds.  Within this chapter, the 
trimethine cyanine fluorophore is explored using three heterocyclic structures, the most 
simple, indolenine to benz[e]indole and the more complex, fused benz[c,d]indole.   
Tricarbocyanine dyes commonly absorb and emit light in the visible region; however, 
varying the conjugated heterocyclic moieties greatly shifts the maximum absorption and 
emission wavelengths. Their binding properties to biomolecules can be studied using 
relative spectrophotometric changes either in absorption or emission spectra 
2.2 Biological Importance of Human Serum Albumin (HSA) 
The transport and release of medication by blood and plasma proteins remains an 
interest within the scope of medicinal chemistry.54-63 The prevalent protein within the 
human plasma is the monomeric 67 kDa Human Serum Albumin (HSA) that is seen 
below in both an atomistic charge to hydrophobicity visualization (left) and the crystal 
structure (right).56, 60-63 
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Figure 2.1 – The 3D depictions of Human Serum Albumin in (left) an atomistic basis 
charge-distribution on the surface and (right) the crystal structure with specific tertiary 
structure.63 
 
This protein has been proven to exhibit a high affinity for many pharmaceutical agents 
and can alter many of their properties, including their half-life and availability to reach the 
intended target, which changes the dosage required for the desired effect.58, 59, 63 The 
binding pocket of HSA does not exhibit specificity toward any particular substrate but 
binds hydrophobic groups well.63 In order to most fully understand the binding to the 
interior hydrophobic pocket of HSA, a series of trimethine cyanine dyes were designed 
with varied hydrophobic heterocycles and indole nitrogen substituents. 
2.3 Protein Arginine Methyl Transferase Introduction 
Protein Arginine Methyl Transferases (PRMTs) are responsible for catalyzing the 
post-translational methylation of nuclear and cytoplasmic proteins by utilizing S-
adenosyl-L-methionine as the methyl donor.64-82  This methylation can be directly linked 
to the regulation of important biological processes.  The mechanism of methylation 
involves the mono- and di-methylation of arginine and the byproduct S-adenosyl-L-
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homocysteine.67-70 This process has been recently associated with various human 
diseases, including increased activity in breast cancer.  The presence of these PRMTs 
has been recognized as a marker for unfavorable prognosis in breast and colon cancer; 
consequently, targeting and inhibiting these enzymatic processes has been a heavily 
researched field and could serve an effective strategy for developing novel anti-cancer 
therapeutics.71-83 In this study, a series of tricarbocyanine dyes were prepared and 
certain structures specifically inhibit the enzymatic activity of PRMT1.  
  
Figure 2.2 – The molecular graphic of the crystal structure of Protein Arginine Methyl 
Transferase 1 with substrate and cofactor bound.83 
 
2.4 Synthesis of Trimethine Cyanines 
The rationale behind designing trimethine cyanine chromophores that are hypothesized 
to interact with human serum albumin includes the incorporation of aliphatic substituents 
to bind effectively in the highly hydrophobic pockets seen in the crystal structure of 
HSA.  Initial synthesis of trimethine cyanine dyes involved the quaternization of the 
2,3,3-trimethylindolenine (1) with ethyl, butyl and phenylpropyl halides followed by 
condensation with triethylorthoformate to afford the final dyes 44-46.  Analogous 
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chemistry was applied using the more highly hydrophobic heterocyclic moiety 2; 
alkylation of 2 afforded the salts 5, 6 and 42.  Condensation with triethyl orthoformate in 
acetic anhydride was performed followed by precipitation with ether and column 
chromatography to obtain the final benz[e]indole trimethine cyanines 47-49. 
 
Figure 2.3 – The synthetic scheme for preparing hydrophobic trimethine cyanines for 
HSA interaction 
 
In order to understand the hydrophobic interactions of these compounds with 
biomolecules, the three-dimensional structure and properties were measured. 
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Figure 2.4 – The molecular modeling results and distribution coefficient data of the 
Fischer indole-based trimethine cyanines (ChemAxon; Budapest, Hungary) 
 
Increasing the hydrophobicity of the tricarbocyanine dye was a rationale objective to 
observe the interaction with the hydrophobic binding pocket.  Switching from the simple 
Fischer indole 1 and benz[e]indole 2 heterocycles toward the fused, compact and most 
aliphatic system, the benz[c,d]indole heterocycle.  Modification of this heterocyclic 
system is more complicated than the previous synthetic methods with the crucial 
synthetic step involving the preparation of the 5-(benz[c,d]indol-1H-2-ylidene)-1,3-
dioxane-4,6-dione intermediate 53. 
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Figure 2.5 – The molecular modeling results and distribution coefficient data of the 
benz[e]indole-based trimethine cyanines (ChemAxon; Budapest, Hungary) 
 
The synthesis of the fused benz[c,d]indole heterocyclic compounds proceeds using 
phosphorus pentasulfide to transform the commercially available compound 50 to the 
thioketone, which is then alkylated upon treatment with methyl iodide. The highly 
reaction intermediate 52 is obtained and correspondingly protected to the dioxo 53.  This 
isolatable intermediate can then be substituted at the heterocyclic nitrogen using various 
alkyl halides; corresponding to the previously synthesized compounds, hydrophobic 
moieties—ethyl, butyl and phenylpropyl—were utilized to compare the effects on 
biomolecular interactions.  The individual salts were subjected to condensation with 
triethyl orthoformate in acetic anhydride to form the final dyes 60-62. 
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Figure 2.6 – The synthetic scheme for preparing hydrophobic trimethine cyanines with a 
benz[c,d]indole heterocyclic system for HSA interaction 
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Figure 2.7 – The molecular modeling results and distribution coefficient data of the 
benz[c,d]indole-based trimethine cyanines (ChemAxon; Budapest, Hungary) 
 
The absorption spectra of each class of dye in 100% methanol are depicted below in 
Figure 2.8.  Comparing the spectra reveals interesting characteristics concerning the 
heterocyclic moieties that require additional investigation and discussion.  Utilizing the 
Fischer-indole base as a control and adding a fused phenyl substituent to the e face of 
the indole heterocyclic induces a bathochromic shift from 546 nm to 586 nm; conversely, 
fusing the additional substituent to the c, d face of the Fischer-indole structure exudes a 
red-shifted maximum absorption to 758 nm.  This effect is due to the increased degree of 
resonance throughout the benz[c,d]indole heterocyclic moieties.  Not only does the 
compact structure allow a higher electron density around the polymethine-bridge which is 
responsible for the generally high wavelengths associated with cyanine dyes, but 
additional resonance structures allows a great stabilization of the excited state which 
means a small energy gap resulting in higher wavelengths.  
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Figure 2.8 – The absorbance versus wavelength (nm) spectra obtained from each N-
ethyl derivative containing the three diverse heterocycles, (left) Shown in purple is the 
indole heterocycle, (middle) The blue graph is the benz[e]indole heterocycle, and (right) 
the red figure is the benz[c,d]indole heterocycle displaying a large shift in wavelength 
maximum.  
 
 
2.5 HSA Binding Study 
Carbocyanine dyes have been extensively employed in bio-analytical chemistry 
due to their ability to sensitively and quantitatively report on their environment.  Spectral 
changes using fluorescent and absorption measurements can be used to extrapolate the 
binding constant of these compounds to various biomolecules.54-63  The spectral change 
that was utilized in this binding study is the phenomenon that cyanine dyes aggregate in 
solution depending on the solvent.  Hydrophobic cyanine dyes will form blue-shifted 
lower wavelength dimers because there is more energy arising from the absorption 
process due to the lack of solvation around the fluorophores.  This dimer is released and 
the monomer peak begins to be seen in higher ratio when the hydrophobicity of the 
solvent is increased as shown in Figure 2.9. 
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Figure 2.9 – Benz[c,d]indole heterocyclic compounds that are depicted to show the 
reduction in dimerization from increasing the hydrophobicity of solvent from 1% methanol 
in water to 100% methanol.  
 
This shows that as the water:methanol ratio decreases and the amount of methanol 
increases, the dimer (left-handed peak) to monomer (right-handed peak) ratio decreases 
and the monomer becomes the more highly populated species in solution.  This was 
then applied to the binding study where as the dye binds to HSA, the dimerization 
process must break to monomer for the compound to enter the hydrophobic pocket of 
the protein.  Binding analysis to HSA was performed using a fixed compound 
concentration and titrating the solution with HSA until there were no discernible spectral 
changes.  The results are shown below in Table 2.1. 
 
 
0.00 
0.10 
0.20 
0.30 
0.40 
0.50 
0.60 
0.70 
0.80 
0.90 
1.00 
1.10 
1.20 
1.30 
1.40 
500 600 700 800 900 
Wavelength (nm) 
Ethyl 
1% 
5% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
0.00 
0.10 
0.20 
0.30 
0.40 
0.50 
0.60 
0.70 
0.80 
0.90 
1.00 
1.10 
500 600 700 800 900 
Wavelength (nm) 
Butyl 
1% 
5% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
0.00 
0.10 
0.20 
0.30 
0.40 
0.50 
0.60 
0.70 
0.80 
0.90 
1.00 
1.10 
500 600 700 800 900 
Wavelength (nm) 
Phenylpropyl 
1% 
5% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100
% 
A
bs
or
ba
nc
e 
A
bs
or
ba
nc
e 
A
bs
or
ba
nc
e 
 34 
Table 2.1 – The photophysical properties obtained from the spectral data and binding 
data with Human Serum Albumin. 
Cyanine Indolium side Abs  Em  
Molar  
Absorptiv-
ity (ε) 
Binding 
Affinities 
(Ka) 
×105M-1 
Quantum 
Yield 
Dye chain (λmax)  (Emmax) M-1cm-1 
(in meth-
anol) 
Benz[c,d]indole             
61 Butyl 758 774 116,000 10.6 0.0047 
60 Ethyl 764 771 143,000 1.55 0.0036 
62 Ph-propyl 758 775 124,000 3.51 0.0061 
Fischer indole             
45 Butyl 531 --- 106,900 8.75 0.0112 
44 Ethyl 529 561 149,500 7.54 0.02 
46 Ph-propyl 532 565 149,100 8.03 0.0058 
Benz[e]indole             
48 Butyl 572 605 103,000 8.33 0.0124 
47 Ethyl 569 603 122,700 3.25 0.0041 
49 Ph-propyl 572 607 117,300 4.14 0.0171 
 
The results of the binding study were unexpected as the predicted results were that the 
binding would increase with increasing hydrophobicity; however, the experiment 
determined that there was an increase in binding when increasing the length of the alkyl 
chain but it was reduced when adding the large and bulky phenyl ring.  This suggests 
that there is a steric restriction toward the binding in the hydrophobic pocket of human 
serum albumin that prevents a high degree of binding with the phenylpropyl substituent.   
 
2.6 PRMT Inhibition and Imaging Study 
The experimental rationale for testing trimethine cyanines for PRMT1 inhibition 
was that the general structure contains heteroatomic nitrogen-centered cations, which 
could competitively bind PRMT and inhibit the methyltransferase activity due to structural 
similarity to arginine residues. In order to determine the inhibitory activity toward PRMT1, 
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the nine trimethine cyanine dyes were subjected to biochemical screening.  The IC50 
data obtained from these experiments is depicted in Table 2.1 and shows a relationship 
between the heterocyclic moiety and the groups on the terminal nitrogen.  The 
compounds are structurally similar with a delocalized positive charge across the 
trimethine bridge.  The molecular variance is within the heterocycles and the 
hydrophobicity and size of the nitrogen substituents and changing either structural 
characteristic greatly influences the inhibitory properties toward PRMT.  The most potent 
compound 60 reveals that perhaps steric hindrance of the nitrogen substituent lowers the 
inhibitory effectiveness by preventing the entry into the binding site of the enzyme.  
When comparing the dyes with different heterocycles, the phenylpropyl dye showed the 
highest potency.  This potentially suggests that a different mode of binding between the 
three sets of compounds; however, only the most effective derivative 60 with ethyl and 
the fused benz[c,d]indole rings with IC50 of 4.1 µM was further examined. 
Table 2.2 – The IC50 (uM) data from biochemical screening of the nine trimethine 
cyanine dyes 44-49 and 60-62. 
 
Fischer-base Heterocycle Compound ID IC50 (uM) 
N-ethyl 44 284.2 
N-butyl 45 160.8 
N-phenylpropyl 46 6.3 
Benz[e]indole Heterocycle Compound ID IC50 (uM) 
N-ethyl 47 20.3 
N-butyl 48 18.0 
N-phenylpropyl 49 14.3 
Benz[c,d]indole Heterocycle Compound ID IC50 (uM) 
N-ethyl 60 4.1 
N-butyl 61 12.0 
N-phenylpropyl 62 15.5 
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Following the promising biochemical characterizations, the possible cellular effects of 60 
were examined using the subcellular localization in HeLa cells. A remarkable and 
appealing feature of trimetine cyanine dyes containing the benz[c,d]indole terminal 
heterocycles is the spectral activity in the NIR region of the electromagnetic spectrum. 
The synthesized analog 60 has absorption maximum at 758 nm and maximum emission 
wavelength of 775 nm, both taken in methanol, which places these compounds well 
outside the region of biomolecular autofluorescence making them ideal intracellular NIR 
imaging agents.  Additionally, these compounds are brightly colored in solution allowing 
ideal colored staining, visible in ambient microscope light.  These imaging experiments 
are depicted in Figure 2.10 A, B, and C show ambient images from the visible light and 
very clearly reveal that this compound 60 enters the HeLa cells and localizes within the 
nucleus with remaining amounts in the cytoplasmic vesicles.  Utilizing the long-
wavelength fluorescence emission of this particular carbocyanine compound, near-
infrared fluorescent imaging of HeLa cells by confocal microscopy was performed using 
a 633 nm laser for fluorescence excitation and a 715 to 785 nm Long Pass for emission. 
Figures 2.10E and 2.10F confirms that after a 6-hour incubation in HeLa cells, the 
compound concentrates around or within the nucleus with a low level being retained in 
the cytoplasmic vesicles, which is consistent with the visible images. The control HeLa 
cells treated with DMSO did not show fluorescent signal (Figure 2.10D). 
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Figure 2.10 – Microscopic Imaging of 60 in HeLa Cells. HeLa cells are treated with 0 
(control), 2, and 5 mM of 60. Figures A, B and C are the optical images of HeLa cells 
captured under visible light by CoolSNAP CF camera attached to a Nikon Ti-80 
microscope. Figures D, E and F are fluorescent images of HeLa cells captured by 
fluorescence confocal microscopy. Performed in collaboration with Creighton University 
Department of Pharmacology. 
 
2.7 Conclusions 
Trimethine cyanine dyes have been shows to absorb and fluoresce from the 
visible region of the electromagnetic spectrum to the NIR range depending of the 
terminal heterocycles.  The hydrophobic interactions of these compounds has been 
proven important in studying the binding pocket of Human Serum Albumin and 
developing inhibitors of Protein Arginine Methyl Transferase.  Activity has been shown to 
depend directly on either the N-indolenine substituent or the heterocyclic structure with 
steric effects contributing significantly to the overall binding ability.  Further work and 
additional analogs should be synthesized and tested for determining the exact mode of 
interaction with both proteins.  In addition, a HeLa cell imaging study revealed the 
intracellular and nuclear localization of a compact and fused dye that shows excellent 
promise and should be examined further.  
A B C
D E F
25)µm
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3 CONCLUSIONS 
Throughout the work presented in this thesis, the synthetic modification of the tri- 
and pentamethine cyanine core yielded specific and strong G-quadruplex binding agents 
that display high affinity for c-myc DNA over both duplex and human telomere DNA; in 
addition, solvatochromic data was utilized to observe spectral changes from 
dimermonomer transitions upon binding to Human Serum Albumin.  These cyanine 
analogs were also potent at inhibiting the enzyme Protein Arginine Methyl Transferase 1 
(PRMT1) with the ability to enter the intercellular space and effectively image HeLa cells 
using both visible light and the inherent fluorescence properties in the NIR region. These 
studies demonstrate that the diverse ability of this molecular class is broad as these 
compounds can be tuned to interact in selective fashion for a multitude of purposes that 
span the breadth of chemistry and chemical biology outside of their otherwise niched 
uses in fluorescent tagging or imaging.  
4  EXPERIMENTAL  
The chemical reagents used in the synthesis of these compounds were obtained 
from either Sigma Aldrich or Alfa Aesar. 1H NMR and 13C NMR spectra were recorded on 
a Bruker Avance (400 MHz) spectrometer using DMSO-d6 or MeOD-d4 containing 
tetramethylsilane (TMS) as an internal calibration standard. UV-Vis/NIR absorption 
spectra were recorded on a Varian Cary 50 spectrophotometer. High-resolution accurate 
mass spectra (HRMS) were obtained either at the Georgia State University Mass 
Spectrometry Facility using a Waters Q-TOF micro (ESI-Q-TOF) mass spectrometer or 
utilizing a Waters Micromass LCT TOF ES+ Premier Mass Spectrometer.  Liquid 
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chromatography utilized a Waters 2487 single wavelength absorption detector with 
wavelengths set between 640 and 700 nm depending on the dye’s photophysical 
properties.  The column used in LC was a Waters Delta-Pak 5 uM 100A 3.9 x 150 mm 
reversed phase C18 column. Evaporative light scattering detection analyzes trace 
impurities that cannot be observed by alternate methods; a SEDEX 75 ELSD was 
utilized in tandem with liquid chromatography to observe purity.  
Synthesis of salts 3-6 with hydrophobic N-indolenine substituents: 
A mixture of indolenine 1 or 2 (31.4 mmol) and alkyl halide (94.2 mmol) were refluxed in 
acetonitrile (25 mL) for 24 hr.  The solvent was and removed in vacuo to afford an oil 
residue. The reaction mixture was cooled in an ice bath and solid was obtained upon 
addition of ether and acetone. The resulting crystals were filtered and dried to yield red 
to light pink solid, which was used without further purification in subsequent reactions. 
1-ethyl-2,3,3-trimethyl-3H-indolium bromide (3): 82% yield; MP 217-221 oC; 1H NMR 
(400 MHz, MeOD-d4) δ 1.60 (t, J = 7.32, 3H), 1.62 (s, 6H), 4.61 (q, J = 7.32 Hz, 2H), 
7.68-7.66 (m, 2H), 7.81-7.80 (m, 1H), 7.94-7.92 (m, 1H). 
 
2,3,3-Trimethyl-1-(3-phenylpropyl)-3H-indolium bromide (4): 81% yield; MP 169-171oC; 
1H NMR (400 MHz, MeOD-d4) δ 1.58 (s, 6H), 2.32 (p, J = 7.6 Hz, 2H), 2.90 (t, J = 7.6 Hz, 
2H), 4.53 (t, J = 8 Hz, 2H), 7.23-7.26 (m, 1H), 7.32-7.34 (m, 4H), 7.63-7.66 (m, 2H), 
7.72-7.76 (m, 2H). 
 
3-Ethyl-1,1,2-trimethyl-1H-benzo[e]indolium bromide (5): 81% yield; MP 225-227 oC; 1H 
NMR (400 MHz, MeOD-d4), δ: 1.50 (t, J = 7.2 Hz, 3H), 1.76 (s, 6H), 2.95 (s, 3H), 4.62 (q, 
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J = 7.2 Hz, 2H), 7.72 (t, J = 7.6 Hz, 1H), 7.79 (t, J = 7.6 Hz, 1H), 8.15 (d, J = 9.2 Hz, 1H), 
8.21 (d, J = 9.2 Hz, 1H), 8.29 (d, J = 9.2 Hz, 1H), 8.36 (d, J = 9.2 Hz, 1H). 
 
1,1,2-Trimethyl-3-(3-phenylpropyl)-1H-benzo[e]indolium bromide (6): Yield 81%, MP 
169-171oC, 1H NMR (400 MHz, MeOD-d4) δ 1.58 (s, 6H), 2.32 (p, J = 7.6 Hz, 2H), 2.906 
(t, J = 7.6 Hz, 2H), 4.531 (t, J = 8 Hz, 2H), 7.231-7.26 (m, 1H), 7.323-7.34 (m, 4H), 7.63-
7.66 (m, 2H), 7.72-7.76 (m, 2H). 
 
Synthesis of hydrophobic dyes 8-11 
Individual indolenine salt 3-6 was added to acetic anhydride (15 mL) and sodium acetate 
(3 mol eq).  The mixture was heated to 50 oC and malonaldehyde bisphenylimine (1 mol 
eq.) was added to the stirring mixture, which caused an instant color change from light 
pink to deep blue-green.  The reactions were monitored using TLC and UV-Vis-NIR 
absorption spectroscopy.  After 2-4 hrs., the reactions were stopped, allowed to cool to 
room temperature then placed in the freezer.  Diethyl ether was added to the reaction 
mixture to precipitate monocationic compounds 8-11. The pure product was isolated 
using column chromatography and a gradient elution ranging from 1:1 EtOAC:DCM to 
2% MeOH in DCM as eluting solvent.   
 
1-Ethyl-2-((1E,3E,5E)-5-(1-ethyl-3,3-dimethylindolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-
dimethyl-3H-indolium bromide (8): Yield 74%; 1HNMR (400 MHz, DMSO-d6) δ: 1.26 (s, 
6H), 1.67 (s, 12H), 4.12 (s, 4H), 6.28 (d, J = 13.2 Hz, 2H), 6.57 (t, J = 12.0 Hz, 1H), 7.24 
(s, 2H), 7.39 (s, 4H), 7.61 (s, 2H), 8.33 (t, J = 12.0 Hz, 2H).  13CNMR (100 MHz, DMSO-
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d6), δ: 12.64, 27.54, 38.98, 49.38, 103.24, 111.33, 122.96, 125.16, 125.86, 128.92, 
141.69, 142.03, 154.62, 172.66. TOF HRMS m/z (M+) calculated for C29H35N2 411.2795, 
found 411.1321. 
 
2-((1E,3E,5E)-5-(3,3-dimethyl-1-(3-phenylpropyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-
3,3-dimethyl-1-(3-phenylpropyl)-3H-indolium bromide (9): Yield 61%; 1HNMR (400 MHz, 
DMSO-d6) δ: 1.68 (s, 12H), 2.01 (t, J = 8 Hz, 4H), 2.74 (t, J = 8 Hz, 4H), 4.15 (t, J = 8 Hz, 
4H), 6.07 (d, J = 12 Hz, 2H), 6.46 (t, J = 12 Hz, 1H), 7.40-7.24 (m ,16H), 7.62 (d, J = 8 
Hz, 2H), 8.33 (t, J = 12 Hz, 2H).  13CNMR (100 MHz, DMSO-d6), δ: 27.60, 29.16, 32.58, 
43.55, 49.40, 103.58, 111.47, 122.93, 125.19, 125.97, 128.71, 128.91, 141.43, 141.59, 
142.46, 154.54, 173.11.  TOF HRMS m/z (M+) calculated for C43H47N2 591.3734, found 
591.1616. 
 
3-Ethyl-2-((1E,3E,5E)-5-(3-ethyl-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)penta-1,3-
dien-1-yl)-1,1-dimethyl-1H-benzo[e]indolium bromide (10): Yield 79%, MP 266-268°C, 1H 
NMR (400 MHz, DMSO-d6) δ 1.33 (t, J = 8.0 Hz, 6H), 1.96 (s, 12H), 4.29 (t, J = 8.0 Hz, 
4H), 6.37 (d, J = 12.0 Hz, 2H), 6.63 (t, J = 12.0 Hz, 1H), 7.51 (t, J = 8 Hz, 2H), 6.68 (t, J 
= 8 Hz, 2H), 7.74 (d, J = 8 Hz, 2H), 8.08 (t, J = 8 Hz, 4H), 8.25 (d, J = 8 Hz, 2H), 8.46 (t, 
J = 12 Hz, 2H).13C NMR (100 MHz, DMSO-d6) δ 11.96, 26.17, 48.04, 50.19, 102.05, 
110.90, 121.58, 124.20, 125.07, 127.11, 127.19, 129.39, 129.83, 130.76, 132.72, 
138.77, 152.54, 172.71. TOF HRMS m/z (M+) calculated for C37H39N2  511.3113, found 
511.3098. 
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2-((1E,3E,5E)-5-(1,1-dimethyl-3-(3-phenylpropyl)-1H-benzo[e]indol-2(3H)-ylidene)penta-
1,3-dien-1-yl)-1,1-dimethyl-3-(3-phenylpropyl)-1H-benzo[e]indolium bromide (11): Yield 
70%, 1H NMR (400 MHz, DMSO-d6) δ 1.94 (s, 12H), 2.04 (m, 4H), 2.78 (t, J = 8 Hz, 4H), 
4.29 (t, J = 6.8 Hz, 4H), 6.27 (d, J = 13.6 Hz, 2H), 6.54 (t, J = 12. 4 Hz, 1H), 7.31-7.16 
(m, 10H), 7.49 (t, J = 7.2 Hz, 2H), 7.71-7.64 (m, 4H), 8.06-8.03 (m, 4H), 8.24 (d, J = 8.4 
Hz, 2H), 8.48 (t, J = 13.2 Hz, 2H). 13C NMR (100 MHz, DMSO-d6) δ 27.24, 29.53, 32.55, 
43.74, 51.19, 103.40, 112.01, 119.44, 122.59, 125.21, 126.54, 128.05, 128.19, 128.73, 
128.90, 130.38, 130.75, 131.74, 133.63, 140.13, 141.49, 153.41, 174.13.  TOF HRMS 
m/z (M+) calculated for C51H51N2  691.4047, found 691.4801. 
Synthesis of indolenine derivatives 15-17 
Phenylhydrazine (10 g) substituted at the 4-position was added to glacial acetic acid 
(100 mL) and was heated to 90 °C.  Acid-catalyzed Fischer-base synthesis proceeds 
upon the addition of 3-methyl-2-butanone (8 mol eq., 11.3 mL).  The solution turned from 
light grey to a deep red and reaction progress was analyzed using TLC (1% 
MeOD/DCM).  After 12-24 hrs., the solution was allowed to cool.  The glacial acetic acid 
was evaporated in vacou.  The remaining residue was diluted using DCM and was 
washed with a 20% solution of sodium bicarbonate, extracted with DCM and dried using 
sodium sulfate.  The final product was obtained as a reddish-brown oil and was used in 
subsequent reactions without further purification. 
 
5-Methoxy-2,3,3-trimethyl-3H-indole (15) Yield 78%, reddish brown oil; 1H NMR (400 
MHz, DMSO-d6) δ 1.166 (s, 6H), 2.159 (s, 3H), 3.684 (s, 3H), 6.739 (m, 2H), 7.380 (s, 
1H). 
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5-Chloro-2,3,3-trimethyl-3H-indole (16): Yield 71%; reddish brown oil; 1H NMR (400MHz, 
MeOD-d4): δ, ppm: 1.28 (s, 6H), 2.25 (s, 3H), 7.38 (m, 3H); 13C-NMR (100MHz, MeOD-
d4): δ, ppm: 14.9, 23.2, 55.4, 121.3, 123.5, 128.9, 132.5, 148.9, 152.5, 191.4. 
 
5-Bromo-2,3,3-trimethyl-3H-indole (17):  Yield 90%; reddish brown oil; 1H NMR 
(400MHz, DMSO-d6): δ, ppm: 1.28 (s, 6H), 2.25 (s, 3H), 7.38 (m, 3H); 13CNMR (100 
MHz, DMSO-d6): δ, ppm: 14.9, 22.1, 53.7, 117.8, 120.9, 124.8, 130.1, 148.3, 152.6, 
188.4. 
 
Synthesis of substituted dicationic salts 18-22 
Indolenine derivatives 1, 2, 15-17 (10 g) were added to acetonitrile (250 mL).  The 
suspension was heated to reflux and 3-bromopropyl trimethylammonium bromide 
(abbreviated BrTMAB) was added (3 mol. eq).  After 72 hours, the reaction was allowed 
to cool and the crude product was obtained upon addition of diethyl ether.  Product 
purification proceeded by recrystallization from methanol using reduced temperature and 
titration with diethyl ether.  The product was filtered and dried using high vacuum as the 
dicationic nature makes these compounds highly hygroscopic.   
 
2,3,3-Trimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium bromide (18): Yield 83%; 
MP 244-246 °C; 1HNMR (400 MHz, DMSO-d6), δ: 1.55 (s, 6H), 2.36 (t, J = 7.2 Hz, 2H), 
2.92 (s, 3H), 3.13 (s, 9H), 3.64 (t, J = 7.4 Hz, 2H), 4.50 (t, J = 7.4 Hz, 2H), 7.65 (d, J = 
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8.0 Hz, 1H), 7.99 (d, J = 8.0 Hz, 1H), 8.01 (s, 1H); 13CNMR (100 MHz, DMSO-d6): δ 
14.5, 21.1, 21.8, 44.9, 52.5, 54.5, 61.6, 114.4, 120.1, 126.0, 140.4, 141.1, 149.0, 198.0. 
 
1,1,2-Trimethyl-3-(3-(trimethylammonio)propyl)-1H-benzo[e]indolium bromide (19):  Yield 
52%; 1HNMR (400 MHz, DMSO-d6), δ: 1.79 (s, 6H), 2.42-2.37 (m, 2H), 3.03 (s, 3H), 3.41 
(s, 9H), 3.65 (t, J = 8.0 Hz, 2H), 4.64 (t, J = 8.0 Hz, 2H), 7.82-7.75 (m, 2H), 8.26 (t, J = 
8.8 Hz, 2H), 8.33 (d, J = 8.8 Hz, 1H), 8.39 (d, J = 8.8 Hz, 1H). 
 
5-Methoxy-2,3,3-trimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium bromide (20): 
Yield 88%; 1HNMR (400 MHz, DMSO-d6), δ: 1.55 (s, 6H), 2.33 (m, 2H), 2.87 (s, 3H), 
3.12 (s, 9H), 3.63 (t, J = 8.4 Hz, 2H), 3.87 (s, 3H), 4.48 (t, J = 8.4 Hz, 2H), 7.16 (d, J = 
8.8 Hz, 1H), 7.58 (s, 1H), 8.03 (d, J = 8.8 Hz, 1H). 
 
5-Chloro-2,3,3-trimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium bromide (21):  Yield 
82%; MP 215-217 °C; 1HNMR (400 MHz, DMSO-d6), δ: 1.65 (s, 6H), 2.56 (t, J = 8.0 Hz, 
2H), 3.25 (s, 9H), 3.73 (t, J = 8.0 Hz, 2H), 4.64 (t, J = 8.0 Hz, 2H), 4.80 (s, 3H), 7.69 (d, J 
= 8.8 Hz, 1H), 7.84-7.92 (m, 2H); 13CNMR (100 MHz, DMSO-d6): δ 12.2, 20.0, 20.7, 
43.3, 52.1, 53.2, 61.5, 115.9, 123.3, 128.8, 134.3, 138.2, 142.3, 197.9. 
 
5-Bromo-2,3,3-trimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium bromide (22): Yield 
81%; MP 225-227 °C; 1HNMR (400 MHz, DMSO-d6), δ: 1.57 (s, 6H), 2.27 (s, 9H), 3.02 
(s, 3H), 3.83 (t, J = 8.0 Hz, 2H), 4.57 (t, J = 8.0 Hz, 2H), 7.61 (m, 2H), 7.88 (t, J = 5.6 Hz, 
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1H). 13CNMR (100 MHz, DMSO-d6): δ 15.2, 22.0, 25.5, 30.6, 52.3, 54.3, 63.9, 115.6, 
123.5, 128.8, 129.3, 140.9, 141.7, 197.7. 
 
Synthetic procedure for preparing tricationic pentacyanine dyes 23-27 
A mixture of individual salts (2 equivalents) and malonaldehyde bisphenylimine 
monohydrochloride (7, 1 equivalent) and sodium acetate (3 equivalents) were refluxed 
for 6 hrs. in anhydrous acetic anhydride under nitrogen atmosphere and then cooled to 
room temperature. The reaction mixture was concentrated in vacou. The crude product 
was dissolved in deionized water and the target compounds were isolated using Sigma 
Aldrich reversed phase silica gel 40-63 µm 90Å C18 column chromatography 
(methanol:water 1:5). 
 
2-((1E,3E,5E)-5-(3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-
dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium bromide (23): Yield 
71%; M.P. 218-221 °C 1HNMR (400 MHz, MeOD-d4): δ 1.78 (s, 12H), 2.35-2.38 (m, 4H), 
3.24 (s, 18H), 3.75 (t, J = 8.4 Hz, 4H), 4.25 (t, J = 7.6 Hz, 4H), 6.62 (d, J = 13.6 Hz, 2H), 
7.14 (t, J = 12.4 Hz, 1H), 7.28-7.32 (m, 2H), 7.43-7.48 (m, 4H), 7.54 (d, J = 7.6 Hz, 2H), 
8.34 (t, J = 13.2 Hz, 2H); 13CNMR (100 MHz, MeOD-d4): δ 20.93, 26.56, 40.26, 49.22, 
52.49, 63.08, 103.72, 110.41, 122.20, 125.07, 127.11, 128.50, 141.23, 141.76, 154.80, 
173.47.  High-resolution electrospray ionization (ESI) accurate mass spectra calculated 
m/z for [C37H55N4]3+ 185.1470 found185.1070; calculated m/z for [C37H55N4]2+ 277.7208, 
found 277.1687. 
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2-((1E,3E,5E)-5-(1,1-dimethyl-3-(3-(trimethylammonio)propyl)-1H-benzo[e]indol-2(3H)-
ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-3-(3-(trimethylammonio)propyl)-1H-
benzo[e]indolium bromide (24): Yield 60%; 1HNMR (400 MHz, MeOD-d4): δ 2.04 (s, 
12H), 2.39 (m, 4H), 3.23 (s, 18H), 3.80 (s, 4H), 4.38 (s, 4H), 6.65 (t, J = 12.8 Hz, 2H), 
7.17 (m, 1H), 7.49 (m, 2H), 7.62 (m, 2H), 7.73 (t, J = 9.2 Hz, 2H), 8.08-7.97 (m, 4H), 8.26 
(t, J = 9.2 Hz, 2H), 8.41 (m, 2H).  13CNMR (100 MHz, MeOD-d4): δ 21.30, 26.32, 40.7, 
51.02, 52.62, 63.10, 103.28, 110.79, 121.97, 124.68, 126.55, 127.35, 128.06, 129.63, 
130.46, 132.02, 132.02, 133.70, 139.16, 153.57, 174.48. High-resolution electrospray 
ionization (ESI) accurate mass spectra calculated m/z for [C45H59N4]3+ 218.4908 found 
218.4383; calculated m/z for [C45H59N4]2+327.7365, found 327.1663.  
 
5-Methoxy-2-((1E,3E,5E)-5-(5-methoxy-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)-3H-indolium bromide (25): Yield 81%; 1HNMR (400 MHz, 
DMSO-d46): δ 1.70 (s, 12H), 2.10 (s, 4H), 3.12 (s, 18H), 3.65 (t, J  = 8.0 Hz, 4H), 3.80 (s, 
6H), 4.15 (t, J = 8.0 Hz, 4H), 6.37 (d, J = 13.6 Hz, 2H), 6.65 (t, J = 12.0 Hz, 1H), 6.94 (d, 
J = 8.8 Hz, 2H), 7.33 (s, 2H), 7.45 (d, J = 8.8 Hz, 2H), 8.30 (t, J = 13.6 Hz, 2H).  13CNMR 
(100 MHz, DMSO-d6): δ 21.30, 27.63, 41.17, 49.63, 52.95, 56.39, 62.82, 103.31, 109.64, 
112.21, 114.00, 125.69, 135.73, 143.32, 153.80, 158.13, 172.34.   High-resolution 
electrospray ionization (ESI) accurate mass spectra calculated m/z for [C39H59N4O2]3+ 
205.1541 found 205.1466; calculated m/z for [C39H59N4O2]2+ 307.7314, found 307.2271. 
 
5-Chloro-2-((1E,3E,5E)-5-(5-chloro-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-
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2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium 
bromide (26): Yield 88%; 1HNMR (400 MHz, MeOD-d4): δ 1.78 (s, 12H), 2.32 (s, 4H), 
3.25 (s, 18H), 3.75 (t, J = 8.4 Hz, 4H), 4.24 (t, J = 7.6 Hz, 4H), 6.60 (d, J = 13.2 Hz, 2H), 
7.11 (t, J = 12.4 Hz, 1H), 7.50-7.43 (m, 4H), 7.58 (s, 2H), 8.35 (t, J = 13.2 Hz, 2H). 
13CNMR (400 MHz, MeOD-d4): δ 20.89, 26.50, 40.58, 49.35, 52.57, 63.05, 104.20, 
111.92, 122.72, 127.75, 128.49, 130.54, 140.59, 143.15, 155.05, 173.28.  High-
resolution electrospray ionization (ESI) accurate mass spectra calculated m/z for 
[C37H53N4Cl2]3+ 207.7877 found 207.7555; calculated m/z for [C37H53N4Cl2]2+ 311.6818, 
found 311.1284. 
 
5-Bromo-2-((1E,3E,5E)-5-(5-bromo-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-
2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium 
bromide (27): Yield 62%;  M.P. 237-240 °C; 1HNMR (400 MHz, MeOD-d4): δ 1.78 (s, 
12H), 2.31 (t, J = 7.1 Hz, 4H), 3.24 (s, 18H), 3.70-3.75 (m, 4H), 4.22 (t, J = 7.2 Hz, 4H), 
6.64 (d, J = 13.6 Hz, 2H), 7.17 (t, J = 12.8 Hz, 1H), 7.38 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 
8.4 Hz, 2H), 7.73 (s, 2H), 8.36 (t, J = 12.8 Hz, 2H); 13CNMR (400 MHz, MeOD-d4): δ 
20.89, 26.06, 26.50, 40.55, 49.32, 52.60, 63.03, 104.27, 112.25, 117.93, 125.63, 131.45, 
141.04, 143.44, 155.07, 173.11 High-resolution electrospray ionization (ESI) accurate 
mass spectra calculated m/z for [C37H53N4Br2]3+ 237.7534 found 237.84; calculated m/z 
for [C37H53N4Br2]2+ 356.6303, found 356.27. 
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Synthesis of halogenated dianil reagents 30 and 31 
Mucobromic acid (5.940 g, 23.04 mmol) was dissolved in ethanol (40 mL) and aniline 
(4.286 g, 4.2 mL, 46.1 mmol), diluted with ethanol (20 mL), was added dropwise over a 
10-minute period.  The reaction vessel was under vigorous stirring and was gently 
heated to 40 oC.  After the addition of aniline was finished, CO2 (g) was further produced 
indicating the reaction was not complete.  Upon completion of CO2 (g) evolution, the 
golden brown reaction mixture was cooled in an ice bath.  Diethyl ether (50 mL) was 
added slowly at reduced temperature under heavy stirring until a bright yellow solid 
precipitated.  The resulting solid was filtered, washed with ether, dried and obtained in 
good yield. 
 
(30): 88% yield. MP 214-216°C; 1HNMR (400 MHz, DMSO-d6), δ: 7.34 (d, J = 7.6 Hz, 
2H), 7.51 (t, J = 7.6 Hz, 4H), 7.67 (d, J = 8.0 Hz, 4H), 9.49 (s, 2H), 11.84 (br. s, 2H); 13C-
NMR (100 MHz, DMSO-d6): δ 100.7, 119.1, 126.7, 129.5, 129.6, 138.6, 155.3. 
 
(31): 75% yield. MP 189-191°C; 1HNMR (400 MHz, DMSO-d6), δ: 7.22 (t, J = 7.6 Hz, 
2H), 7.47 (t, J = 7.6 Hz, 4H), 7.71 (d, J = 7.6 Hz, 4H), 9.57 (s, 2H), 11.51 (br. s, 2H); 13C-
NMR (100 MHz, DMSO-d6): δ 89.3, 119.5, 123.9, 126.0, 129.2, 129.6, 138.5, 157.4. 
 
Synthesis of trihalogenated pentamethine cyanines 32-41  
2-((1E,3Z,5E)-3-chloro-5-(3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-
ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indolium 
bromide (32): 46% yield. MP 225-227 °C; 1HNMR (400 MHz, DMSO-d6): δ 1.81 (s, 12H), 
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2.40 (t, J = 7.4 Hz, 4H), 3.26 (s, 18H), 3.71-3.79 (m, 4H), 4.38 (t, J = 7.6 Hz, 4H), 6.55 
(d, J = 13.4 Hz, 2H), 7.36 (t, J = 7.2 Hz, 2H), 7.50 (t, J = 7.6 Hz, 2H), 7.58 (d, J = 7.6 Hz, 
2H), 7.63 (d, J = 7.6 Hz, 2H), 8.50 (d, J = 13.4 Hz, 2H); 13CNMR (100 MHz, DMSO-d6), 
δ: 20.9, 26.0, 40.7, 49.4, 52.5, 63.0, 100.9, 111.9, 122.2, 123.2, 125.6, 128.6, 141.4, 
141.7, 148.2, 175.1.  HRMS (ESI) calculated for [C37H54ClN4]3+ m/z 196.7742, found m/z 
197.1837. 
 
2-((1E,3Z,5E)-3-chloro-5-(1,1-dimethyl-3-(3-(trimethylammonio)propyl)-1H-benzo[e]indol-
2(3H)-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-3-(3-(trimethylammonio)propyl)-1H-
benzo[e]indolium bromide (33): 62% yield; 1HNMR (400 MHz, MeOD-d4): δ 2.04 (s, 
12H), 2.264 (s, 4H), 3.15 (s, 18H), 3.70 (t, J = 8.0 Hz, 4H), 4.42 (s, 4H), 6.40 (d, J = 13.2 
Hz, 2H), 7.56 (d, J = 7.6 Hz, 2H), 7.73 (t, J = 7.6 Hz, 2H), 7.96 (d, J = 9.2 Hz, 2H), 8.17-
8.11 (m, 4H), 8.28 (d, J = 8.8 Hz, 2H), 8.73 (d, J = 13.2 Hz, 2H).  13CNMR (100 MHz, 
MeOD-d4), δ: 20.89, 26.50, 40.58, 49.35, 52.57 63.05, 104.20, 111.92, 122.72, 127.75, 
128.49, 130.54, 140.59, 143.15, 155.05, 173.28.  High-resolution electrospray ionization 
(ESI) accurate mass spectra calculated m/z for [C45H58N4Cl]3+ 229.8111 found 229.7517; 
calculated m/z for [C45H58N4Cl]2+ 344.7170, found 344.6516. 
2-((1E,3Z,5E)-3-chloro-5-(5-methoxy-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-
2-ylidene)penta-1,3-dien-1-yl)-5-methoxy-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-
3H-indol-1-ium bromide (34): 88% yield; 1HNMR (400 MHz, DMSOd6): δ 1.74 (s, 12H), 
2.16 (s, 4H), 3.12 (s, 18H), 3.63 (t, J = 8.4 Hz, 4H), 3.83 (s, 6H), 4.23 (s, 4H), 6.24 (d, J = 
13.6 Hz, 2H), 6.98 (d, J = 8.8 Hz, 2H), 7.40 (s, 2H), 7.55 (d, J = 8.8 Hz, 2H), 8.45 (d, J = 
13.6 Hz, 2H).  13CNMR (100 MHz, DMSOd6) δ: 21.25, 27.23, 41.73, 50.19, 52.82, 56.47, 
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62.78, 99.94, 109.63, 113.03, 122.66, 135.50, 143.68, 147.10, 158.71, 173.67.  High-
resolution electrospray ionization (ESI) accurate mass spectra calculated m/z for 
[C39H58N4O2]3+ 216.4744 found 216.4743; calculated m/z for [C39H58N4O2]2+ 324.7119, 
found 324.34. 
5-Chloro-2-((1E,3Z,5E)-3-chloro-5-(5-chloro-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)-3H-indol-1-ium bromide (35): 77% yield. MP 222-224°C; 
1HNMR (400 MHz, DMSO-d6): δ 1.76 (s, 12H), 2.17 (t, J = 7.2 Hz, 4H), 3.13 (s, 18 H), 
3.65 (tt, J = 7.6 Hz, J = 7.2 Hz, 4H), 4.27 (t, J = 7.6 Hz, 4H), 6.34 (d, J = 13.6 Hz, 2H), 
7.51 (d, J = 8.4 Hz, 2H), 7.70  (d, J = 8.4 Hz, 2H), 7.93 (s, 2H), 8.73 (d, J = 13.6 Hz, 2H); 
13CNMR (100 MHz, DMSO-d6), δ: 20.7, 26.4, 41.3, 49.7, 52.3, 62.1, 100.3, 113.3, 123.2, 
123.5, 128.3, 130.0, 140.5, 143.4, 148.4, 174.3. Composition in theory: (x3H2O): C 
(46.63%), H (6.13%), N (5.88%); Composition found: С (46.22%), H (6.12%), N (5.78%); 
HRMS (ESI) calculated for [C37H52Cl3N4]3+ m/z 219.7376, found m/z 219.1727. 
 
5-Bromo-2-((1E,3Z,5E)-5-(5-bromo-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-
2-ylidene)-3-chloropenta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-
indol-1-ium bromide (36): 80% yield. MP 227-229°C; 1HNMR (400 MHz, DMSO-d6): δ 
1.76 (s, 12H), 2.17 (t, J = 7.0 Hz, 4H), 3.12 (s, 18H), 3.58-3.68 (m, 4H), 4.26 (t, J = 6.8 
Hz, 4H), 6.35 (d, J = 13.4 Hz, 2H), 7.61 (d, J = 8.6 Hz, 2H), 7.65 (d, J = 8.6 Hz, 2H), 8.05 
(s, 2H), 8.56 (d, J = 13.4 Hz, 2H); 13CNMR (400 MHz, DMSO-d6), δ: 20.7, 26.4, 41.2, 
49.7, 52.3, 62.2, 100.3, 113.7, 118.1, 123.5, 126.0, 131.3, 140.4, 143.5, 148.7, 174.9. 
Composition in theory: (x3H2O): C (42.65%), H (5.61%), N (5.38%); Composition found: 
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С (42.09%), H (5.80%), N (5.26%); HRMS (ESI) calculated for [C37H52Br2ClN4]3+ m/z 
249.3716, found m/z 248.9238. 
 
2-((1E,3Z,5E)-3-bromo-5-(3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-
ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-indol-1-ium 
bromide (37): 66% yield. MP 174-176°C; 1HNMR (400 MHz, DMSO-d6): δ 1.77 (s, 12H), 
2.31 (t, J = 7.1 Hz, 4H), 3.13 (s, 18H), 3.58-3.68 (m, 4H), 4.34 (t, J = 7.0 Hz, 4H), 6.40 
(d, J = 13.2 Hz, 2H), 7.61 (d, J = 8.6 Hz, 2H), 7.76 (d, J = 8.6 Hz, 2H), 8.11 (s, 2H), 8.61 
(d, J = 13.2 Hz); 13CNMR (100 MHz, DMSO-d6), δ: 22.4, 27.6, 42.2, 51.8, 54.0, 64.2, 
112.3, 118.3, 123.2, 127.1, 130.8, 143.6, 151.3, 176.1. Composition in theory: C (50.82), 
H (6.22), N (6.41); Composition found: С (50.48), H (6.75), N (6.45).  
 
2-((1E,3Z,5E)-3-bromo-5-(1,1-dimethyl-3-(3-(trimethylammonio)propyl)-1H-
benzo[e]indol-2(3H)-ylidene)penta-1,3-dien-1-yl)-1,1-dimethyl-3-(3-
(trimethylammonio)propyl)-1H-benzo[e]indol-3-ium bromide (38): 71% yield; 1HNMR 
(400 MHz, MeOD-d4), δ: 2.05 (s, 12H), 2.46 (s, 4H), 3.28 (s, 18H), 3.84 (t, J = 8.0 Hz, 
4H), 4.51 (s, 4H), 6.54 (d, J = 13.2 Hz, 2H), 7.49 (t, J = 7.2 Hz, 2H), 7.67 (t, J = 7.2 Hz, 
2H), 7.89 (d, J = 8.8 Hz, 2H), 7.99 (d, J = 8.0 Hz, 2H), 8.09 (d, J = 8.8 Hz, 2H), 8.27 (d, J 
= 8.0 Hz, 2H), 8.62 (d, J = 13.2, 2H). 13CNMR (100 MHz, MeOD-d4), δ: 21.17, 25.99, 
39.07, 41.27, 51.65, 52.54, 63.18, 102.23, 110.94, 117.03, 122.14, 125.20, 127.57, 
127.96, 129.73, 130.67, 132.43, 134.42, 138.94, 149.36, 176.29.  High-resolution 
electrospray ionization (ESI) accurate mass spectra calculated m/z for [C45H58BrN4]3+ 
244.4610 found 245.0591; calculated m/z for [C45H58BrN4]2+ 366.6917, found 367.0858. 
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2-((1E,3Z,5E)-3-bromo-5-(5-methoxy-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-5-methoxy-3,3-dimethyl-
1-(3-(trimethylammonio)propyl)-3H-indol-1-ium bromide (39): 90% yield; 1HNMR (400 
MHz, DMSO-d6), δ: 1.73 (s, 12H), 2.18 (s, 4H), 3.15 (s, 18H), 3.67 (J = 8.0 Hz, 4H), 3.82 
(s, 6H), 4.22 (s, 4H), 6.23 (d, J = 13.2 Hz, 2H), 6.97 (d, J = 8.4 Hz, 2H), 7.39 (s, 2H), 
7.58 (d, J = 8.2 Hz, 2H), 8.49 (d, J = 13.2 Hz, 2H).  13CNMR (400 MHz, DMSO-d6), δ: 
21.22, 27.23, 41.83, 50.22, 52.84, 56.50, 62.80, 102.34, 109.65, 113.09, 114.25, 116.44, 
135.49, 143.68, 149.00, 158.71, 173.80.  High-resolution electrospray ionization (ESI) 
accurate mass spectra calculated m/z for [C39H58BrO2N4]3+ 231.1242 found 231.2; 
calculated m/z for [C39H58BrO2N4]2+ 347.6856, found 347.3. 
2-((1E,3Z,5E)-3-bromo-5-(5-chloro-3,3-dimethyl-1-(3-(trimethylammonio)propyl)indolin-2-
ylidene)penta-1,3-dien-1-yl)-5-chloro-3,3-dimethyl-1-(3-(trimethylammonio)propyl)-3H-
indol-1-ium bromide (40): 88% yield. MP 238-240°C; 1HNMR (400 MHz, DMSO-d6): δ 
1.77 (s, 12H), 2.19 (t, J = 7.6 Hz, 4H), 3.13 (s, 18H), 3.63 (tt, J = 7.6 Hz, J = 7.8 Hz, 4H), 
4.25 (t, J = 7.8 Hz, 4H), 6.34 (d, J = 13.4 Hz, 2H), 7.53 (d, J = 8.0 Hz, 2H), 7.68 (d, J = 
8.0 Hz, 2H), 7.94 (s, 2H), 8.61 (d, J = 13.4 Hz, 2H); 13CNMR (400 MHz, DMSO-d6), δ: 
18.5, 20.6, 26.4, 41.4, 49.8, 52.3, 62.2, 102.7, 113.3, 117.0, 123.2, 128.3, 130.1, 140.5, 
143.4, 150.3, 174.4. Composition in theory: (x3H2O): C (44.56%), H (5.86%), N (5.62%); 
Composition found: С (44.54%), H (5.78%), N (5.56%); HRMS (ESI) calculated for 
[C37H52BrCl2N4]3+ m/z 234.5546, found m/z 234.0587. 
 
5-Bromo-2-((1E,3Z,5E)-3-bromo-5-(5-bromo-3,3-dimethyl-1-(3-
(trimethylammonio)propyl)indolin-2-ylidene)penta-1,3-dien-1-yl)-3,3-dimethyl-1-(3-
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(trimethylammonio)propyl)-3H-indol-1-ium bromide (41): 77.6% yield. MP 232-234°C; 
1HNMR (400 MHz, DMSOd6): δ 1.76 (s, 12H), 2.18 (t, J = 7.1 Hz, 4H), 3.12 (s, 18H), 
3.55-3.65 (m, 4H), 4.24 (t, J = 7.0 Hz), 6.34 (d, J = 13.2 Hz, 2H), 7.60 (d, J = 8.6 Hz, 2H), 
7.66 (d, J = 8.6 Hz, 2H), 8.06 (s, 2H), 8.60 (d, J = 13.2 Hz); 13CNMR (400 MHz, 
DMSOd6), δ: 20.66, 26.46, 41.37, 49.79, 52.35, 62.25, 102.70, 113.74, 116.99, 118.22, 
126.03, 131.24, 140.93, 143.72, 150.42, 174.34. Composition in theory: (x3H2O): C 
(40.91%), H (5.38%), N (5.16%); Composition found: С (40.77%), H (5.68%), N (5.26%); 
HRMS (ESI) calculated for [C37H52Br3N4]3+ m/z 264.1886, found m/z 264.2249. 
 
Synthesis of additional hydrophobic salts 42 and 43 
A mixture of indolenine 1 or 2 (31.4 mmol) and alkyl halide (94.2 mmol) were refluxed in 
acetonitrile (25 mL) for 24 hr.  The solvent was and removed in vacuo to afford an oil 
residue. The reaction mixture was cooled in an ice bath and solid was obtained upon 
addition of ether and acetone. The resulting crystals were filtered and dried to yield red 
to light pink solid, which was used without further purification in subsequent reactions. 
 
1-Butyl-2,3,3-trimethyl-3H-indol-1-ium iodide (42): Yield 77%, 1H NMR (400 MHz, 
DMSO-d6), δ: 1.096 (t, J = 7.6 Hz, 3H), 1.62-1.57 (m, 2H), 1.68 (s, 6H), 2.05-1.97 (m, 
2H), 4.59 (t, J = 7.6 Hz, 2H), 4.88 (s, 3H), 7.71 (s, 2H), 7.84 (s, 1H), 7.97 (s, 1H). 
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Synthesis of trimethine cyanine dyes with indole 44-46 and benz[e]indole 47-49 
heterocycles 
Quaternized ammonium salts 3-6, 42, 43 were heated to 80 oC in acetic anhydride. 
Triethyl orthoformate was added to the reaction mixture causing an instant color change 
from bright red to deep purple.  The reaction mixture was monitored by UV/Vis 
spectroscopy in methanol and TLC analysis using DCM as the mobile phase. After 2 hr. 
the reaction was stopped and the flask was cooled in a freezer. After 2 hr., and titration 
with diethyl ether, the product precipitated and was filtered and dried. Initial product 
purification was performed by recrystallization using minimum amounts of methanol, 
reduced temperature, and addition of ether. Compounds 24, 26 and 27 were additionally 
purified using silica gel and 2% MeOH in dichloromethane as eluting solvent. 
 
1-Ethyl-2-((1E,3E)-3-(1-ethyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-3,3-dimethyl-
3H-indolium iodide (44). Yield 77%, 1H NMR (400 MHz, MeOD-d4) δ 1.43 (t, J = 8 Hz, 
6H), 1.77 (s, 12H), 4.22 (q, J = 8 Hz, 4H), 6.53 (d, J = 12 Hz, 2H), 7.31 (t, J = 8 Hz, 2H), 
7.36 (d, J = 8 Hz, 2H), 7.45 (t, J = 8 Hz, 2H), 7.55 (d, J = 8 Hz, 2H), 8.56 (t, J = 12 Hz, 
1H); 13C NMR (100 MHz, MeOD-d4) δ 12.69, 28.25, 40.35, 103.44, 112.23, 123.60, 
126.77, 130.04, 142.34, 142.95, 152.32, 175.63; TOF HRMS m/z (M+) calculated for 
C27H33N2 385.2644, found 385.2647. λmax/em =  546/561 nm in methanol. 
 
1-Butyl-2-((1E,3E)-3-(1-butyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-3,3-dimethyl-
3H-indol-1-ium (45). Yield 74%, mp 172-175 oC, 1H NMR (400 MHz, DMSO) δ 0.95 (t, J 
= 8 Hz, 6H), 1.41-1.54 (m, 4H), 1.71 (s, 12H), 1.68-1.80 (m, 4H), 4.14 (t, J= 8 Hz, 4H), 
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6.52 (d, J = 16 Hz, 2H), 7.31 (t, J = 8 Hz, 2H), 7.46 (q, J = 8 Hz, 4H), 7.65 (d, J = 16 Hz, 
2H), 8.37 (t, J = 12 Hz, 1H); 13C NMR (MeOD-d4)  δ 13.81, 19.57, 27.46, 29.21, 43.70, 
48.90, 102.50, 111.56, 122.50, 125.20, 128.64, 140.61, 141.87, 173.84; TOF HRMS m/z 
(M+) calculated for C31H41N2 441.3270, found 441.3279. λmax/em =  546/561 nm in 
methanol. 
 
1-Phenylpropyl-2-((1E,3E)-3-(1-butyl-3,3-dimethylindolin-2-ylidene)prop-1-en-1-yl)-3,3-
dimethyl-3H-indol-1-ium (46). Yield 67%, mp 255-258 oC,1H NMR (400 MHz, MeOD-d4) 
δ 1.74 (s, 12H), 2.18 (p, J = 7.2 Hz, 4H), 2.85 (t, J = 7.5 Hz, 4H), 4.18 (t, J= 7.8 Hz, 4H), 
6.21 (d, J = 13.3 Hz, 2H), 7.45 (t, J = 8 Hz, 2H), 7.55 (d, J = 8 Hz, 2H), 8.56 (t, J = 12 Hz, 
1H); 13C NMR (100 MHz, MeOD-d4) δ 24.64, 28.30, 29.97, 33.74, 44.65, 103.69, 112.37, 
123.56, 126.82, 127.45, 129.61, 129.71, 129.98, 142.08, 142.21, 143.27, 175.96; TOF 
HRMS m/z (M+) calculated for C27H33N2 385.2644, found 385.2647. λmax/em =  546/561 
nm in methanol. 
 
3-Ethyl-2-((1E,3E)-3-(3-ethyl-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)prop-1-en-1-
yl)-1,1-dimethyl-1H-benzo[e]indol-3-ium iodide (47): Yield 66%, mp >260 oC, 1H NMR 
(400 MHz, MeOD-d4) δ 1.50 (t, J = 8 Hz, 6H), 2.10 (s, 12H), 4.34 (q, J = 8 Hz, 4H), 6.53 
(d, J = 16 Hz, 2H), 7.53 (t, J = 8 Hz, 2H), 7.65 (d,  J = 8 Hz, 2H), 7.67 (d,  J = 8 Hz, 2H), 
8.03 (d,  J = 8 Hz, 2H), 8.06 (d,  J = 12 Hz, 2H), 8.29 (d,  J = 8 Hz, 2H), 8.79 (t,  J = 8 Hz, 
1H); 13C NMR (100 MHz, MeOD-d4) δ 13.13, 28.07, 40.68, 52.59, 102.96, 112.14, 
123.49, 126.49, 129.07, 129.55, 131.34, 132.16, 133.82, 140.59; TOF HRMS m/z (M+) 
calculated for C35H37N2 485.2957, found 485.2960. λmax/em =  586/605 nm in methanol. 
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3-Butyl-2-((1E,3E)-3-(3-butyl-1,1-dimethyl-1H-benzo[e]indol-2(3H)-ylidene)prop-1-en-1-
yl)-1,1-dimethyl-1H-benzo[e]indol-3-ium iodide (48): Yield 63%,1H NMR (400 MHz, 
MeOD-d4) δ 1.06 (t, J = 8 Hz, 6H), 1.55-1.61 (m, 4H), 1.88-1.94 (m, 4H), 2.11 (s, 12H), 
4.20 (t, J = 8 Hz, 4H), 6.56 (d, J = 12 Hz, 2H), 7.53 (t,  J = 8 Hz, 2H), 7.64 (d,  J = 8 Hz, 
2H), 7.69 (t,  J = 12 Hz, 2H), 8.03 (d,  J = 8 Hz, 2H), 8.06 (d,  J = 8 Hz, 2H), 8.30 (d, J = 
8Hz, 2H), 8.79 (t, J = 12 Hz, 1H); 13C NMR (100 MHz, MeOD-d4):  δ  14.41, 21.11, 
21.36, 28.18, 31.13, 52.56, 103.27, 112.37, 123.50, 126.52, 129.09, 129.48, 131.34, 
132.10, 133.80, 135.10, 141.02; TOF HRMS m/z (M+) calculated for C39H45N2 541.3583, 
found 541.3582. λmax/em =  586/605 nm in methanol. 
 
2-((1E,3E)-3-(1,1-dimethyl-3-(3-phenylpropyl)-1H-benzo[e]indol-2(3H)-ylidene)prop-1-en-
1-yl)-1,1-dimethyl-3-(3-phenylpropyl)-1H-benzo[e]indol-3-ium iodide (49): Yield 55%,1H 
NMR (400 MHz, MeOD-d4) δ 2.01 (s, 12H), 2.12 (p, J = 8 Hz, 4H), 2.82 (t, J = 8 Hz, 4H), 
4.31 (t, J = 8 Hz, 4H), 6.39 (d, J = 12 Hz, 2H), 7.21-7.33 (m, 12H), 7.55 (t, J = 8 Hz, 2H), 
7.74 (t, J = 8 Hz, 2 H), 7.75 (d, J = 8 Hz, 2H), 8.11 (t, J = 8 Hz, 4H), 8.30 (d, J = 8 Hz, 2 
H), 8.58 (t, J = 12 Hz, 1H); 13C NMR (100 MHz, MeOD-d4) δ 26.60, 28.76, 32.32, 101.59, 
110.65, 121.92, 125.01, 126.08, 127.55, 127.90, 127.99, 128.07, 128.21, 128.34, 
129.78, 130.55, 132.27, 139.29, 140.62. TOF HRMS m/z (M+) calculated for C49H49N2 
665.3896, found 665.3893. λmax/em = 586/605 nm in methanol. 
 
Benz[c,d]indole-2(1H)-thione (51): This compound was obtained in an 93% yield; mp 
146-148 oC; (reported: yield 82%, mp 156 °C.) 
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2-Methylthiobenz[c,d]indole hydroiodide (52): This compound was prepared using the 
reported procedures.  Since the product was unstable, it is used in the next step without 
further purification. 
 
2-(2,2-Dimethyl-4,6-dioxo-1,3-dioxane-5-yliden)1Hbenz[c,d]indole (53): This compound 
was obtained in an 85% yield; mp 220 oC; (reported: yield 94%, mp 223 °C). 
 
General Procedures of the Synthesis of Compounds 54-56  
A mixture of compound 53 (10.2 mmol), alkyl iodide (3 mol eq.) and K2CO3 (3 mol eq.) 
were heated in DMF (40 mL) at 90 °C for 20 hrs. The mixture was cooled to room 
temperature and then filtered. The filtrate was concentrated under reduced pressure. 
The residue was purified using flash column chromatography and 1:2 EtOAc:hexanes as 
the eluting solvent. 
1-Ethyl-2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-1H-benz[c,d]indole (54): Yield 
65%, mp 183-184oC; 1H NMR (400 MHz, DMSO-d6) δ 1.46 (t, J = 7 Hz, 3 H), 1.70 (s, 6 
H), 4.39 (q, J = 7 Hz, 2 H), 7.78 (m, 1 H), 7.91 (m, 2 H), 8.01 (m, 1 H), 8.40 (d, J = 8 Hz, 
1 H), 8.90 (d, J = 8 Hz, 1 H).  
 
1-Butyl- 2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-1H-benz[c,d]indole (55): Yield 
74 %, 1H NMR (400 MHz, DMSO-d6) δ 0.86 (t, J = 7.5 Hz, 3 H), 1.27 (q, J = 7.2, 2 H), 
1.75 (s, 6 H), 1.82 (p, J = 6.6 Hz, 2 H), 3.39 (t, J = 7.5 Hz, 2 H), 7.79 (t, J =7.5 Hz, 1 H), 
 58 
7.94 (t, J = 7.8 Hz, 1 H), 8.02 (d, J = 7.2 Hz, 1 H), 8.06 (d, J = 8.4 Hz, 1 H), 8.45 (d, J = 
8.1 Hz, 1 H), 8.91 (d, J = 7.2 Hz, 1 H). 
 
1-Phenylpropyl-2-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-1H-benz[c,d]indole (56): 
Yield 92 %, mp 155-157 oC 1H NMR (400 MHz, DMSO-d6) δ 2.17 (m, 2 H), 2.56 (t, J = 7 
Hz, 2 H), 4.35 (t, J = 7 Hz, 2 H), 7.17 (m, 5 H), 7.71(d, J = 7.5 Hz, 1 H), 7.86 (m, 2 H), 
7.88 (t, J =  7.5 Hz, 1 H),  8.38 (d, J = 8 Hz, 1 H), 8.88 (d, J = 8 Hz, 1 H). 
 
General Procedures of the Synthesis of Salts 57-59  
 
Ester 54-56 (2.9 mmol) was dissolved in acetic acid (4 mL) and the mixture was refluxed 
for 20 min. Concentrated HCl (4 mL) was added dropwise to the refluxing mixture until 
the color changed from red to green. The mixture was cooled to room temperature, and 
saturated KI solution was added until the product started to precipitate. The product was 
filtered off, washed with ether, and dried in vacuo affording quaternary ammonium salts 
57-59 in good yield. 
 
1-Ethyl-2-(2-dimethylaminovinyl)benz[c,d]indolium iodide (57). Yield 76 %, mp 242-244 
oC ; 1H NMR (400 MHz, DMSO-d6) δ 1.56 (t, J = 7 Hz, 3 H), 4.46 (s, 3 H), 4.71 (q, J = 7 
Hz, 2 H), 8.0 (m, 1 H), 8.19 (m, 1 H), 8.45 (d, J = 8 Hz, 1 H), 8.54 (d, J = 8 Hz, 1 H), 8.69 
(d, J = 8 Hz, 1 H), 8.79 (d, J =8 Hz, 1 H).  
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1-Butyl-2-(2-dimethylaminovinyl)benz[c,d]indolium iodide (58): Yield 82 %, 1H NMR (400 
MHz, DMSO-d6) δ 0.86 (t, J = 7.5 Hz 3 H), 1.27 (m, 2 H), 1.75 (s, 6 H), 1.82 (p, J = 6.6 
Hz, 2 H), 4.39 (t, J = 7.5 Hz, 2 H), 7.79 (t, J = 8.1 Hz, 1 H), 7.94 (t, J =  7.5 Hz, 1 H), 8.02 
(d, J = 7.2 Hz, 1 H),  8.07 (d, J = 8.4 Hz, 1 H), 8.45 (d, J = 8.1 Hz, 1 H), 8.91 (d, J = 7.2 
Hz, 1 H). 
1-Phenylpropyl-2-(2-dimethylaminovinyl)benz[c,d]indolium iodide (59): Yield 86 %, mp 
75-76 oC 1H NMR (400 MHz, DMSO-d6) δ 2.26 (m, 2 H), 2.28 (t, J = 7 Hz, 2 H), 4.00 (s, 
3 H), 4.70 (t, J = 7 Hz, 2 H), 7.14 (m, 5 H), 7.96 (t, J = 7.5 Hz, 1 H), 8.10 (t, J =  7.5 Hz, 1 
H), 8.41 (m, 2 H),  8.48 (d, J = 8 Hz, 1 H), 8.92 (d, J = 8 Hz, 1 H). 
 
General Synthetic Strategy for Final Dye Compounds 60-62 
 
A mixture of the individual salts 57-59 triethylorthoformate (5 mol eq.), anhydrous sodium 
acetate (3 mol eq.) and 4 ml of acetic anhydride was boiled for 1 h. The dye was suction 
filtered, washed with ethyl ether and dried. 
 
1-Ethyl-2-[3-(1-ethylbenz[c,d]indol-2(1H)-ylidene)-1-propen-1-yl]-iodide (60). Yield 75%; 
1H NMR (400 MHz, DMSO-d6) δ 1.40 (t, J = 7 Hz, 3H), 4.36 (d, J = 7 Hz, 2H), 6.90 (d, J 
= 13 Hz, 1H), 7.20 (m, 1H), 7.57 (d, J = 7.5 Hz, 1H), 7.66 (t, J = 7.5 Hz, 1H), 7.80 (d, J = 
8.10 Hz, 1H), 7.97 (t, J = 7.5 Hz, 1H), 8.27 (d, J = 8.10 Hz, 1 H), 8.78 (t, J = 13 Hz, 1 H), 
8.94 (d, J = 7.5 Hz, 1H).  TOF HRMS m/z (M+) calculated for C29H25N2 401.2018, found 
401.2000. λmax/em = 758/774 nm in methanol. 
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1-Butyl-2-[3-(1-butyllbenz[c,d]indol-2(1H)-ylidene)-1-propen-1-yl]- iodide (61). Yield 60 
%, 1H NMR (400 MHz, DMSO-d6) δ 0.96 (t, J = 7.2 Hz, 6H), 1.43-1.50 (m, 4H), 1.85 (p, J 
= 6.6 Hz, 4H), 4.40 (t, J = 6.6 Hz, 4H), 7.23 (d, J = 13.2 Hz, 4H), 7.72-7.77 (m, 4H), 7.86-
7.90 (m, 4H), 8.06 (t, J = 7.5 Hz, 2H), 8.36 (d, J = 8.1 Hz, 1H), 8.66 (d, J = 7.2 Hz, 2H), 
9.20 (t, J = 13.2 Hz, 1H). TOF HRMS m/z (M+) calculated for C33H33N2 457.2644, found 
457.2624. λmax/em = 758/774 nm in methanol. 
 
1-Phenylpropyl-2-[3-(1-phenylpropylbenz[c,d]indol-2(1H)-ylidene)-1-propen-1-yl]iodide 
(62): Yield 48%, 1H NMR (400 MHz, DMSO-d6), δ: 2.06 (m, 2H), 2.75 (t, J = 7 Hz, 2H), 
4.27 (t, J = 7 Hz, 2H), 6.75 (d, J = 13.6 Hz, 1H), 6.97 (m, 1H), 7.24 (m, 5H), 7.46 (d, J = 
7.5 Hz, 1H),  7.63 (t, J = 8 Hz, 1H), 7.76 (d, J = 8 Hz, 1H), 7.94 ( t, J = 7.5 Hz, 1H),   8.25 
(d, J = 8 Hz, 1H), 8.73 (t, J = 13 Hz, 1H), 8.87 (d, J = 8 Hz, 1H). TOF HRMS m/z (M+) 
calculated for C43H37N2 581.2957, found 581.2934. λmax/em = 758/774 nm in methanol. 
 
HSA Studies Experimental84 
Laser Induced Fluorescence emission spectra were acquired using a K2 Spectro-
fluorometer (ISS, Champaign, IL) equipped with a R298 Hamamatu Photomultiplier Tube 
(Bridgewater, NJ). Excitation was achieved with GaAlAs laser diodes (Laser Max, Roch-
ester, NY) at 690 nm. Slit widths were set to 2 mm and integration time of 3 s. Absorption 
measurements were achieved with a Perkin-Elmer Lambda UV/VIS/NIR (Lambda 50) 
Spectrophotometer (Norwalk, CT). All measurements were performed in 1 cm quartz cu-
vette (VWR, Suwanee, GA, USA). 
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Cyanine dyes’ hydrophobicity was studied by acquiring absorbance and emission 
scans of the dyes in varying ratios of methanol-deionized water mixture (in the range of 0 
to 100% methanol/water) until no further discernable spectral changes, at which point the 
spectra overlapped at percent methanol increased. 
The HSA binding studies were conducted by titrating a fixed volume of dye solu-
tions at constant concentration of dye (10 µM for absorbance and 1.0 µM for emission) 
with HSA until there were no further spectral changes with further additional of the HSA. 
Each sample was vortexed for 30 s and then left for 5 min to equilibrate. A fresh batch of 
the biomolecule solution was prepared every 24 h period. (Human Serum Albumin stud-
ies were performed in collaboration with Dr. Gabor Patonay’s laboratory and Garfield 
Beckford at Georgia State University). 
Protein Expression and Purification85 
PRMT1-pET28b plasmid was transformed into Escherichia coli BL21 (DE3) using 
heat shock method. Protein expression was induced with 0.3-mM IPTG at 16ºC for 20 h. 
After protein expression, cells were pelleted by centrifuge followed by suspension in the 
lysis buffer (25 mM HEPES pH 8.0, 150 mM NaCl, 1 mM PMSF, 1 mM MgSO4, 5% 
glycerol, 5% ethylene glycol) and lysed by French Press. The protein supernatant was 
purified on the Ni-charged His-tag binding resin (Novagen). The beads were equilibrated 
with column buffer (25 mM Na-HEPES pH 8.0, 500 mM NaCl, 1 mM PMSF, and 30 mM 
imidazole, 10% glycerol, 1 mM PMSF) followed by protein loading. After that the beads 
were washed thoroughly with the column buffer, and then the protein was eluted with the 
elution buffer (25 mM Na-HEPES, pH 7.0, 300 mM NaCl, 1 mM PMSF, 100mM EDTA 
and 200 mM imidazole, 5% glycerol). Different elution fractions were checked on SDS–
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PAGE. Then, protein fractions were combined and dialyzed against the storage buffer 
(25 mM Na-HEPES, pH 7.0, 500 mM NaCl, 1 mM EDTA, 10 mM DTT and 10% glycerol) 
at 4 ºC. After dialysis, the protein solution was concentrated using Millipore centrifugal 
filters. His6x-tagged PRMT3 was expressed from the pReceiver vector. GST-mCARM1 
was expressed from the pGEX-4T1 vector. His6x-tagged PRMT5 and PRMT6 were ex-
pressed from the pET28a vector. All of the proteins were expressed in Escherichia coli 
BL21(DE3). All of the His6x-tagged proteins were purified on Ni-NTA beads. Protein 
concentrations were determined using Bradford assay. 
Radioactive Methyltransferase Assay85 
The inhibitory activities of small molecule compounds were examined by using 
14C-labeled radioactive methylation assays. The assays were carried out in 0.6 mL plas-
tic tubes at 30°C in a reaction volume of 30 µL. The reaction buffer contained 50 mM 
HEPES (pH 8.0), 0.5 mM dithiothreitol (DTT), 1 mM EDTA, and 50 mM NaCl. In a typical 
procedure, peptide substrate, [14C]- S-Adenosyl-L-methionine and inhibitor were prein-
cubated in the reaction buffer for 5 min prior to the initiation by the addition of PRMT1 
(0.05 µM final). After it was incubated for 8 min, the reaction was quenched by spreading 
the reaction mixture onto P81 filter paper discs (Whatman). The paper disk was washed 
with 50 mM NaHCO3, and dried in air for 2 h. The amount of methylated products was 
quantified by liquid scintillation. To determine the IC50 value of those inhibitors similar 
experiment was performed with H4-(1-20) (2 µM), [14C]- S-Adenosyl-L-methionine (5 µM) 
and DMSO (2%) and varied concentration of inhibitors. The IC50 value is the concentra-
tion of inhibitor at which half of the maximal activity is reached.  
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Bright Field and Fluorescent Microscopic Imaging85 
HeLa cells were seeded on coverglass overnight and treated without or with different 
concentrations of 60 for 6 hours. Cells were then fixed by 4% paraformaldehyde for 10 
min at room temperature. Then the optical images were taken under visible light by 
CoolSNAP CF camera attached to a Nikon Ti-80 microscope. The NIR fluorescent 
images were taken by an LSM META NLO confocal microscope (Creighton university 
Integrated biomedical imaging Facility) using a 633-nm laser and a 715 to 785-nm Long 
Pass filter. 
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APPENDICES 
Appendix A – Chapter 1: 1HNMR, 13CNMR, and HRMS Spectra: 
1H NMR and 13C NMR spectra were recorded on a Bruker Avance (400 MHz) spec-
trometer	  and	  high-resolution accurate mass spectra (HRMS) were obtained either at the 
Georgia State University Mass Spectrometry Facility using a Waters Q-TOF micro (ESI-
Q-TOF) mass spectrometer or utilizing a Waters Micromass LCT TOF ES+ Premier 
Mass Spectrometer. 
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Appendix B – Chapter 2: 1HNMR, 13CNMR, and HRMS Spectra: 
1H NMR and 13C NMR spectra were recorded on a Bruker Avance (400 MHz) spec-
trometer	  and	  high-resolution accurate mass spectra (HRMS) were obtained either at the 
Georgia State University Mass Spectrometry Facility using a Waters Q-TOF micro (ESI-
Q-TOF) mass spectrometer or utilizing a Waters Micromass LCT TOF ES+ Premier 
Mass Spectrometer.	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